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Heat shock protein 70s (Hsp70s) and their DnaJ co-factors exist in all organisms and in all eukaryotic
organelles. These highly conserved chaperone pairs facilitate a large number of cellular processes. ERdj3
was identified as a soluble, lumenal DnaJ family member that binds to unassembled immunoglobulin
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cells. Here we demonstrate that ERdj3 binds directly to two unfolded substrates: immunoglobulin γHC
and denatured firefly luciferase. Using mutagenesis studies on ERdj3 in both in vivo and in vitro binding
assays, we defined ERdj3’s critical amino acids in domain I that contribute to substrate binding and
demonstrated that ERdj3 forms dimers, which are important for substrate binding. We suggested that
these features are conserved among all type I and type II DnaJ proteins. Somewhat unexpectedly, we
found that domain II, which is highly conserved among ERdj3 homologues but very different from domain
II of Ydj1, was also essential for substrate binding. Recent studies have demonstrated that Hsp70s can
interact in vitro with some but not all DnaJ proteins from different organelles or even different organisms.
To better understand restrictions on Hsp70/DnaJ interactions, we expressed ERdj3 in both the yeast ER
and cytosol. Our data revealed that the ability to complement loss of the resident DnaJ proteins in either
of these organelles was most dependent on its ability to interact with the resident Hsp70. Mutations in
ERdj3 that affected substrate binding were unable to complement loss of Ydj1, arguing that substrate
binding ability is also important. Finally, previous studies suggested that DnaJ proteins often bind to
unfolded substrates initially and recruit their Hsp70 partners. DnaJ proteins stimulate the ATPase activity
of its Hsp70 partner and induce a conformational change in the Hsp70 to stabilize its binding to
substrate. By some unknown mechanism the DnaJ protein is then released. We established an in vitro
model to examine the requirements for the release of ERdj3 from substrates and found that BiP promoted
the release of ERdj3 only in the presence of ATP. Mutations in ERdj3 or BiP that disrupted their interaction
interrupted the release of ERdj3. BiP mutants that cannot bind to ATP or undergo a nucleotide-induced
conformational change were also unable to release ERdj3. These results demonstrate that a functional
interaction between ERdj3 and BiP, including both a direct interaction and the ability to stimulate BiP’s
ATPase activity are required to release ERdj3 from substrate. Furthermore they suggest that the
interaction with BiP may induce a reciprocal change in ERdj3 that triggers its release from substrates.
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ABSTRACT
Heat shock protein 70s (Hsp70s) and their DnaJ co-factors exist in all organisms
and in all eukaryotic organelles. These highly conserved chaperone pairs facilitate a
large number of cellular processes. ERdj3 was identified as a soluble, lumenal DnaJ
family member that binds to unassembled immunoglobulin heavy chains (HC) along with
the BiP chaperone complex in the endoplasmic reticulum of mammalian cells. Here we
demonstrate that ERdj3 binds directly to two unfolded substrates: immunoglobulin γHC
and denatured firefly luciferase. Using mutagenesis studies on ERdj3 in both in vivo and
in vitro binding assays, we defined ERdj3’s critical amino acids in domain I that
contribute to substrate binding and demonstrated that ERdj3 forms dimers, which are
important for substrate binding. We suggested that these features are conserved among
all type I and type II DnaJ proteins. Somewhat unexpectedly, we found that domain II,
which is highly conserved among ERdj3 homologues but very different from domain II
of Ydj1, was also essential for substrate binding. Recent studies have demonstrated that
Hsp70s can interact in vitro with some but not all DnaJ proteins from different organelles
or even different organisms. To better understand restrictions on Hsp70/DnaJ
interactions, we expressed ERdj3 in both the yeast ER and cytosol. Our data revealed
that the ability to complement loss of the resident DnaJ proteins in either of these
organelles was most dependent on its ability to interact with the resident Hsp70.
Mutations in ERdj3 that affected substrate binding were unable to complement loss of
Ydj1, arguing that substrate binding ability is also important. Finally, previous studies
suggested that DnaJ proteins often bind to unfolded substrates initially and recruit their
Hsp70 partners. DnaJ proteins stimulate the ATPase activity of its Hsp70 partner and
induce a conformational change in the Hsp70 to stabilize its binding to substrate. By
some unknown mechanism the DnaJ protein is then released. We established an in vitro
model to examine the requirements for the release of ERdj3 from substrates and found
that BiP promoted the release of ERdj3 only in the presence of ATP. Mutations in ERdj3
or BiP that disrupted their interaction interrupted the release of ERdj3. BiP mutants that
cannot bind to ATP or undergo a nucleotide-induced conformational change were also
unable to release ERdj3. These results demonstrate that a functional interaction between
ERdj3 and BiP, including both a direct interaction and the ability to stimulate BiP’s
ATPase activity are required to release ERdj3 from substrate. Furthermore they suggest
that the interaction with BiP may induce a reciprocal change in ERdj3 that triggers its
release from substrates. Based on similarities among DnaJs and Hsp70s, this is likely to
be applicable to other Hsp70/DnaJ pairs.
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CHAPTER 1. INTRODUCTION
1.1

Protein Folding

Proteins are fundamental components of all organisms and participate in every
process within cells. To be functional in cells, proteins have to fold and achieve their
correct three-dimensional structure. The primary structure of a protein is a linear chain of
amino acids that based on the properties of the amino acid side chains form a secondary
structure of which the α-helix and β-sheet are the most common ones. The amino acids
that form the secondary structure then interact with each other and produce a completely
folded, functional tertiary or in some cases quaternary structure.
Most folded proteins have a hydrophobic core inside the molecule formed by the
side chains of the hydrophobic residues, which stabilize the protein, and charged or polar
residues on the surface that interact with water molecules nearby. It is believed that the
guiding principle of protein folding is to make the smallest number of hydrophobic sidechains exposed to the surface (Pace et al., 1996). Using both chemically or temperature
denatured ribonuclease as the substrates, Christian Anfinsen showed that denatured
ribonuclease could fold back to a functional shape by itself with the removal of
denaturing chemicals or by lowering the temperature (Anfinsen, 1972). He concluded
that all of the information required to fold a protein is encoded in the protein itself and
that the amino acid sequence determines the shape of the protein. This discovery won
him the Nobel Prize in Chemistry in 1972. Anfinsen’s study was performed in vitro
using a very dilute single protein, and folding started with a full length linear
unstructured chain. Compared to in vitro conditions, the in vivo folding environment is
much more crowded with many different types of nascent proteins, and folding often
occurs co-translationally, so that the N-terminus of the protein begins to fold while the Cterminal portion of the protein is still being synthesized by the ribosome. In many cases,
parts of the protein that will ultimately interact with each other come from very distant
regions of the linear polypeptide chain.
1.2

Molecular Chaperones

Although proteins are able to achieve their native state on their own in isolation, it
soon became appreciated that many of the proteins synthesized in cells needed additional
help to either promote folding or prevent misfolding. The term “molecular chaperone”
was first used by Ron Laskey in 1978 to describe the ability of nucleoplasmin, a nuclear
protein, to prevent the aggregation of folded histone proteins with DNA during the
assembly of nucleosomes (Laskey et al., 1978). Nucleoplasmin did not bind to
nucleosomes or DNA, but instead was found to interact with histones to cover their
positive charges. John Ellis extended the term in 1987 to define molecular chaperones as
proteins that mediate the post-translational assembly of protein complexes (Ellis, 1987),
but which are not themselves components of the final complex nor do they determine the
final structure of a protein. However, once folding is complete the chaperones leave their
client protein and move on to assist the folding of another protein. In 1988, it was
1

determined that chaperones assisting in this process are conserved in both prokaryotes
and eukaryotes (Hemmingsen et al., 1988).
There are two major families of chaperones that have been discovered:
GroEL/GroES and Hsp70/DnaJs. GroEL is a highly conserved and ubiquitously
expressed bacterial protein that is required for the proper folding of many proteins. To
function properly, GroEL requires the assistance of the lid-like co-chaperone protein
GroES. Within the cell, partially folded substrate proteins bind to a hydrophobic binding
patch on the interior rim of the open cavity of GroEL and finish folding within this space
(Martin et al., 1993). In eukaryotes, the mitochondrial proteins Hsp60 and Hsp10 are
homologues of GroEL and GroES (Hartl, 1991; Tabibzadeh & Broome, 1999) and TricC
is a cytosolic orthologue, which functions independently of a small co-chaperone
(Frydman et al., 1992).
Hsp70 is a large family of proteins that is highly conserved and homologues have
been found in all organisms and all organelles. Hsp70 proteins were originally named
based on their size of ~70kDa and their induction by heat shock. The Hsp70 proteins are
composed of an N-terminal nucleotide binding domain and a C-terminal substrate
binding domain. The main function of this group of proteins is to bind in a nucleotidedependent manner to relatively short extended regions on polypeptide chains and prevent
them from aggregating. Using peptides to stimulate the ATPase activity of these
proteins, it was discovered that peptides of ~5-10 amino acids in length that were
relatively hydrophobic in nature were most likely to bind the Hsp70 protein (Flynn et al.,
1989; Flynn et al., 1991). The recognition sequence was further defined using phage
peptide display libraries (Blond-Elguindi et al., 1993; Fourie et al., 1994) or by screening
cellulose bound peptides (Rudiger et al., 1997). These studies revealed that peptides
composed of four or five amino acids with hydrophobic residues in alternating positions
were mostly likely to bind. This was in keeping with the polypeptide chain being in an
extended form with the hydrophobic residues pointing in the same direction (BlondElguindi et al., 1993). This idea was confirmed when a crystal structure was solved with
a short peptide in the peptide binding domain of DnaK, the E. coli Hsp70 (Zhu et al.,
1996). These binding sites are usually buried in the folded proteins and only available for
the Hsp70 protein to bind when the substrate is in the unfolded form (Rudiger et al.,
1997). Although the binding of GroEL and Hsp70 both rely on the hydrophobicity of the
substrate, GroEL has a relatively low affinity for short peptides and prefers substrate
peptides that have the capability to form some secondary structure such as an α-helix,
whereas Hsp70 recognizes completely unfolded regions of the substrate (Landry et al.,
1992; Hayer-Hartl et al., 1994; Okazaki et al., 1994).
1.2.1 Hsp70 proteins
All of the Hsp70 proteins can be divided into four major domains. An N-terminal
domain encodes a highly conserved ~44 kD nucleotide binding domain (NBD) that can
bind ATP or ADP. A small flexible linker follows the NBD and links it to a ~18 kD
substrate binding domain (SBD) that binds to unfolded polypeptides. The C-terminal
portion is a less conserved 10 kD lid domain, which is involved in capping the SBD. The
2

NBD domain consists of two major lobes that form the nucleotide binding site. The
substrate binding domain forms a β-sandwich, whereas the 10 kD lid domain is mainly αhelical (Zhu et al., 1996). The SBD contains a groove that can interact with the
hydrophobic region on the unfolded or mis-folded proteins. All Hsp70 proteins have a
weak ATPase activity, which is indispensable for binding to substrates. Binding of ATP
or ADP regulates the interaction between Hsp70 and substrate. When the Hsp70 is in
ATP bound form, the lid is open and allows peptides to bind to the SBD and release from
it relatively rapidly. With the hydrolysis of ATP to ADP, Hsp70 undergoes a
conformational change that causes the lid close allowing the SBD to associate with
peptides tightly. The replacement of ADP with ATP induces another conformational
change that reopens the lid and releases the substrate from the SBD (Munro and Pelham,
1986; Liberek et al., 1991; Buchberger et al., 1995). The ATPase cycle of Hsp70 is
tightly controlled by regulators that either induce the ATPase activity (e.g. DnaJ proteins)
or regulate nucleotide exchange (nucleotide exchange factors and nucleotide exchange
inhibitors) (Figure 1-1). These co-chaperones are involved in the intramolecular
communication between the ATPase and substrate binding domains and regulate
association between Hsp70 and substrate (Freeman et al., 1995).
1.2.2 Mammalian ER Hsp70
Immunoglobulin heavy chain binding protein (BiP), which was found to associate
with the unassembled, non-secreted Ig heavy chain produced in pre-B lymphoid cell
lines, was the first identified chaperone of the endoplasmic reticulum (Haas & Wabl,
1983). BiP interacts with various Ig assembly intermediates in plasmacytoma cells but
not with completely assembled mature Ig molecules (H2L2) (Bole et al., 1986). Cloning
of the mammalian BiP gene revealed that it was a member of the Hsp70 gene family
(Munro et al., 1986; Haas & Meo, 1988), suggesting that it was likely to play an
important role in the folding and assembly of secretory pathway proteins. In addition to
its role in protein folding and assembly (Gaut & Hendershot, 1993; Simons et al., 1995;
Lee et al., 1999; Vanhove et al., 2001), BiP contributes to ER calcium storage (Roy &
Lee, 1995; Lievremont et al., 1997), targeting mis- or unfolded proteins to the
proteosome for degradation (Buchberger et al., 1995; Skowronek et al.,1998; Zhang et
al., 2001; Kabani et al., 2003; Okuda-Shimizu and Hendershot, 2007), and regulating the
UPR signal transducers (Bertolotti et al., 2000; Molinari et al., 2002;Shen et al., 2002).
Furthermore, during early stages of translocation, BiP contributes to the maintenance of
the permeability barrier of the ER translocon (Hamman et al., 1998), which is necessary
to maintain a proper ER environment when nascent chains enter the secretory pathway
(Figure 1-2). All of these BiP functions, except calcium storage, require its ATPase
activity.
1.3

Hsp40/DnaJ Protein

Genetic studies isolated a number of genes in E. coli that are required for DNA
replication of λ phage. Two of these genes, DnaJ and DnaK, are required for both host
cell and λ phage DNA replication (Yochem et al., 1978). DnaJ is a ~43 kD protein that
3

Figure 1-1.

Hsp70s’ ATPase cycle and substrate binding

Hsp70s alternate between ATP and ADP bound forms. Hsp70s associate and release
substrate rapidly in ATP-bound form, whereas they bind and release substrate slowly in
the ADP-bound form. DnaJ proteins stimulate the ATPase activity of Hsp70 and induce
the hydrolysis of ATP to ADP. Nucleotide exchange factors (NEF) trigger the switch of
ADP to ATP and reset the cycle. Nucleotide exchange inhibitors block the replacement
of ADP with ATP.
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Figure 1-2.

BiP’s multiple functions in ER

BiP is involved in multiple processes in the mammalian ER including maintaining the
permeability barrier of the ER translocon, assisting nascent polypeptide chain folding and
assembly, targeting misfolded protein for degradation, contributing to ER calcium storage
and sensing ER stress. All these functions except contributing to calcium storage require
its ATPase activity which can be regulated by ER DnaJ proteins.

5

can interact with DnaK and serve to stimulate the ATPase activity of DnaK, which is
necessary for its chaperone activity (Liberek et al., 1991). Later studies recognized that
many proteins possessed a domain that was very similar to the N-terminal 70 amino acids
of DnaJ, which was named the J domain, and proteins that had this domain were called
DnaJ proteins (Cheetham & Caplan, 1998; Walsh et al., 2004). Like Hsp70, DnaJ
proteins are found in all organisms and organelles, but the number of DnaJ proteins far
exceeds the Hsp70 proteins in any given organelle. For example, in the mammalian ER,
6 DnaJ proteins have been identified, whereas only one Hsp70 is present.
Based on their domain conservation with E. coli DnaJ, DnaJ proteins can be
divided into three classes (Hennessy et al., 2000). Class I DnaJ proteins have the highest
domain homology with E. coli DnaJ and possess all four domains. The N-terminal region
encodes the ~70 amino acid J domain (Bardwell et al., 1986). There is a hallmark HisPro-Asp (HPD) tri-peptide motif in the middle of J domain (Liberek et al., 1991;
Cheetham et al., 1998), which plays a key role in the interaction with DnaK (Wall et al.,
1994). A glycine/phenylalanine-rich flexible domain (G/F) follows the J domain. The C
terminus includes a cysteine-rich domain containing four CysXXCys motifs that form
two Zn2+ atoms binding sites (Banecki et al., 1996; Szabo et al., 1996) and the substrate
binding domain (Liberek et al., 1990). The Gly/Phe region is not only the linker between
J and C-terminal domains, but also is crucial for J domain’s interaction with Hsp70 and
for DnaJ function. Recently, crystallographic studies on the C-terminal fragment of
Ydj1, a type I DnaJ protein in the yeast cytosol, revealed that the Cys-rich domain is a
separate domain that is encoded within the linear sequence of the substrate binding
domain (Li et al., 2003). The two halves of the substrate binding domain fold together to
form a substrate binding pocket (Li & Sha, 2005) (Figure 1-3). Class II DnaJ proteins
have an N-terminal J domain and the Gly/Phe-rich linker, but lack the Zn2+ binding
domain. The substrate binding domain of Sis1, a yeast cytosolic class II DnaJ protein
was crystallized without a peptide substrate (Sha et al., 2000). Although its amino acid
homology it not high with the substrate binding domain of Ydj1, they both share a very
similar tertiary structure. Class III proteins only contain a J domain, which can occur
anywhere in the protein. Some class III proteins also bind to substrate, although in no
case has the substrate binding domain been clearly defined. For example, auxilin which
contains a C-terminal J-domain can bind to clathrin and assists the uncoating of clathrincoated vesicles (Gruschus et al., 2004). SV 40 large T-antigen contains an N-terminal J
domain and binds to p53 directly (Peden et al., 1989; DeCaprio, 1999). P58IPK, a
recently identified mammalian ER DnaJ protein can interact with newly synthesized
secretory proteins in vitro (Rutkowski et al., 2007) and possesses a C-terminus J domain
(Melville et al., 1997). Generally, class I and II proteins share a higher level of
conservation in the J domain than class III proteins do. Since they have less conserved J
domains and lack a Gly/Phe-rich and Cys-rich regions, class III proteins may require
higher specificity for their Hsp70 partner and substrates and only recognize a restricted
subset of substrates.

6

Figure 1-3.

Three types of DnaJ family members

DnaJ proteins are divided into 3 subgroups, according to the domain conservation with
E.coli DnaJ which consists of ~70 amino acid J domain (HPD motif), Gly/Phe rich
domain, Cys-rich Zn2+ finger domain (domain II) and C-terminal domain. Type I and II
DnaJ proteins are similar except that type II lacks domain II. Type III only contains J
domain which can occur anywhere in the molecule. Recent studies indicate that domain I
which is bisected in type I DnaJ contains substrate binding site.

7

1.3.1 Yeast DnaJ homologues
There are three DnaJ proteins in the yeast ER and thirteen in the cytosol (Cheetham
& Caplan, 1998). Among these three ER DnaJ proteins, Scj1p is a class I DnaJ protein,
and the other two, Sec63p and Jem1p, belong to class III. Sec63p is a transmembrane
protein with a J domain that faces ER lumen and cooperates with Kar2p, a yeast Hsp70,
to translocate proteins into the ER co- and post-translationally (Rothblatt et al., 1989;
Sadler et al., 1989; Brodsky et al., 1995; Corsi & Schekman, 1997). Unlike Sec63p,
which is required for cell growth, Scj1p (Schlenstedt et al., 1995) and Jem1p (Nishikawa
& Endo, 1997) are soluble ER luminal proteins that are not essential for cell viability
under normal growth conditions. However, loss of both JEM1 and SCJ1 causes a slow
growth phenotype at elevated temperatures. Scj1p interacts with Kar2p to assist protein
folding and assembly in the ER lumen (Schlenstedt et al., 1995). The fact that the ΔScj1
mutant is hypersensitive to tunicamycin and mutations that block N-linked glycosylation,
is consistent with Scj1’s role in assisting protein folding (Silberstein et al., 1998). Jem1p
interacts with Kar2p to mediate nuclear membrane fusion (Nishikawa & Endo, 1997). In
the yeast cytosol, there are thirteen DnaJ proteins identified that form distinct
DnaJ/Hsp70 pairs to assist in Hsp70’s various chaperone functions (Sahi & Craig, 2007).
One of them, Ydj1, a class I DnaJ protein, binds to the cytosolic side of the ER
membrane through its C-terminus farnesylation site and is required for cell growth
(Caplan & Douglas, 1991). Sis1, an essential gene that cannot be replaced by Ydj1 (Luke
et al., 1991), belongs to the class II subgroup (Sha et al., 2000; Li et al., 2005).
1.3.2 Mammalian ER DnaJ homologues
In the mammalian ER, six DnaJ proteins have been identified and named ERdj1-6.
All of them interact with BiP through their J domain and stimulate its ATPase activity in
vitro. ERdj1/Mtj1, is a transmembrane ER protein that binds the ribosome through its
cytosolic domain and interacts with BiP through its luminal domain and is thought to
couple translation with folding (Brightman et al., 1995; Chevalier et al., 2000; Dudek et
al., 2002) and ERdj2/hSec63 (Skowronek et al., 1999; Tyedmers et al., 2000), the
mammalian homologue of Sec63, is a multi-transmembrane ER proteins that belongs to
the class III subgroup. Both of these proteins are associated with Sec61 and Sec62 and
act as co-chaperones of BiP to translocate nascent polypeptides into the ER.
ERdj3/HEDJ (Yu et al., 2000; Lau et al., 2001; Meunier et al., 2002), a 43 kD ER
lumenal soluble DnaJ protein, was first identified as a shiga toxin binding protein. Shiga
toxin is endocytosed from the plasma membrane and recognized by the cell as an
unfolded protein. As such it is transported back to the ER and then is retrotranslocated to
the cytosol to perform its function (Sandvig et al., 1992; Johannes & Goud, 2000).
Independently, ERdj3 was identified as a component of the chaperone complex that binds
to free Ig heavy chains in mouse plasmacytoma lines (Meunier et al., 2002). ERdj3 is
induced by ER stress, up-regulated during B cell differentiation and is most highly
expressed in secretory tissues (Shen & Hendershot, 2005; Shen & Hendershot, 2007).
These data suggest that ERdj3 is likely to serve as a cofactor for BiP in regulating protein
folding, preventing aggregation, or targeting proteins for degradation. The fact that in
ERdj3 knock out cells, the turn-over of free HC is increased argues that ERdj3 is most
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probably involved in protein folding and preventing aggregation (Shen et al., unpublished
data). Homologues of ERdj3 are found in all metazoans and are highly conserved.
ERdj3 has been suggested to be the orthologue of yeast Scj1, since both are ER lumen
proteins and have similar size. ERdj4/Mdj1 (Prols et al., 2001; Shen et al., 2002) is a
trans-membrane protein with its uncleaved signal peptide inserted into the ER membrane.
The rest of the protein resides inside the ER where its J domain interacts with BiP. Like
ERdj3, ERdj4 has the highest expression level in secretory tissues and is induced by ER
stress (Shen et al., 2002). ERdj5, which contains four protein-disulfide isomerase
domains (Cunnea et al., 2003; Hosoda et al., 2003) is a ubiquitous, abundant protein in
the ER of cells. Recent data suggests that it may play role in either disulfide bond
formation or reduction in the ER (Dong et al., 2008). ERdj6/P58IPK (Rutkowski et al.,
2007) is the most recently identified member of the ER DnaJ family of proteins and is
induced by ER stress and facilitates protein maturation (Figure 1-4).
1.4

Nucleotide Exchange Factors

To release the substrate from Hsp70 proteins, ADP must be released and ATP
reinserted into the nucleotide binding domain. GrpE is a nucleotide exchange factor
(NEF) found in bacteria, which binds to the ATPase domain of DnaK, induces the
replacement of ADP with ATP, and triggers the release of unfolded substrates (Liberek et
al., 1991; Szabo et al., 1994). Mge1p, a soluble mitochondrial matrix protein in S.
cerevisiae is a GrpE homolog, acting in concert with mitochondrial hsp70 in protein
translocation (Laloraya et al., 1994; Westermann et al., 1995). GrpE homologues also
have been found in mammalian mitochondria that bind to mitochondria Hsp70 in an ADP
dependent manner (Bolliger et al., 1994; Naylor et al., 1995; Naylor et al., 1998). SSE1
is the yeast homolog of mammalian NEF Hsp110 and acts as an efficient NEF for yeast
cytosolic Hsp70 (Raviol et al., 2006). Although GrpE homologues are not present in
other eukaryotic organelles, a number of both positive and negative regulators of
nucleotide exchange have been identified. Hip binds to the ATPase domain of Hsc70 and
stabilizes it in the ADP-bound state (Hohfeld et al., 1995; Prapapanich et al., 1996).
BAG-1, a Bcl-2 binding anti-apoptotic factor was found to be able to promote the
exchange of ADP to ATP in Hsp70 (Hohfeld & Jentsch, 1997; Stuart et al., 1998).
HspBP1 enhances nucleotide exchange for Hsp70 in vitro (Raynes & Guerriero, Jr.,
1998). Structural studies of GrpE with the ATPase domain of DnaK (Harrison et al.,
1997) and the Bag-1/Hsc70 complex (Sondermann et al., 2001) provided insights into the
mechanism of nucleotide exchange. Binding of the exchange factors to the ATPase
domain of their Hsp70 triggers the release of substrate from Hsp70, which is achieved
through the conserved conformational change in the ATPase domain of Hsp70.
A genetic screen identified the first nuclear exchange factor for the yeast ER
Hsp70, Kar2p. SLS1 interacts directly with the ATPase domain of Kar2p and stimulates
ATP hydrolysis by promoting ADP release in yeast Yarrowia lipolytica (Boisrame et al.,
1998; Kabani et al., 2000; Tyson & Stirling, 2000). Per100p (Travers et al., 2000) and
Sil1p (Tyson & Stirling, 2000) are the homologues of SLS1 in S. cerevisiae. Using the
ATPase domain of a BiP mutant as bait in a yeast two-hybrid screen, BAP (BiPAssociated Protein) was indentified as a nucleotide exchange factor for BiP in the
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Figure 1-4.

Characterization of mammalian ER DnaJ proteins

Six DnaJ proteins are identified in mammalian ER and named ERdj1-6 according the
order they are found.
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mammalian in ER (Chung et al., 2002). BAP is an ER-localized glycoprotein that shows
the highest expression levels in secretory pathway tissues. Although BAP releases both
ATP and ADP from BiP in vitro, BAP prefers the ADP-bound form of BiP (Chung et al.,
2002), which may allow BAP to drive the ATPase cycle of BiP forward.
In the yeast ER, Lhs1p was shown to be able to substitute for Sil1p and to represent
an alternative nucleotide exchange activity. Lhs1 is a member of what has been referred
to as the large Hsp70 family of proteins (Craven et al., 1996). These proteins show a
high degree of homology at their N-terminus to Hsp70 proteins but contain large Cterminal extensions. GRP170, a mammalian orthologue of Lhs1p, has nucleotide
exchange activity for BiP in vitro (Dierks et al., 1996), suggesting it can be an alternative
exchange factor for BiP. In some mammalian cells, the function of BAP/Sil1 appears to
be essential. Mutations that cause the loss function of Sil1 have been identified in
humans and cause Marinesco–Sjögren syndrome, an autosomal dominant
neurodegenerative disease (Senderek et al., 2005; Anttonen et al., 2008). A SIL1 knockout mouse or “woozy” mouse has been generated, which shows similar evidence of
neurodegeneration (Zhao et al., 2005). The relationship between SIL1 mutations and
Marinesco-Sjögren syndrome indicates that dysfunction of chaperone assisted protein
folding in the endoplasmic reticulum can cause multisystem disorders (Sondermann et
al., 2001; Senderek et al., 2005; Anttonen et al., 2008).
1.5

Protein Folding in the ER

The endoplasmic reticulum (ER) is a membrane-enclosed organelle found in all
eukaryotic cells. The ER provides a specialized environment for the synthesis, folding,
and assembly of nearly all proteins destined for secretion and cell surface expression.
Secretory pathway and ER resident proteins are synthesized on ER membrane associated
ribosomes in the cytosol. A hydrophobic signal sequence (~11-20 amino acids), which
usually occurs on the N-terminus of the nascent polypeptide chain, is required to direct it
to the translocon and allow it to be translocated into ER (Lingappa et al., 1978). After
entering the ER, the signal sequence of the nascent polypeptide is often removed.
Subsequently, glycans can be added to the nascent chain after ~14 amino acids have
entered the lumen of the ER. Oligosaccharyl-transferase (OST) can co-translationally
add N-linked glycans to asparagine residues in N-X-S/T site where asparagine is
followed by any amino acid except proline and then a serine or threonine (Whitley et al.,
1996). The OST complex is associated with the translocon and N-linked glycosylation
serves to monitor the folding of the nascent chain. Nascent unfolded polypeptides are
highly concentrated in the ER of a secretory cell. Unlike most organelles, an unusually
high proportion of proteins in the ER are unfolded proteins or unassembled subunits that
will ultimately be delivered out of ER for further transport along the secretory pathway
once they are mature.
The ER environment is also unique in that it provides additional advantages and
exerts certain restrictions to protein folding and assembly. The ER possesses an
oxidizing environment and contains a group of enzymes that allow and assist the
formation of disulfide bonds between adjacent cysteine residues (Hwang et al., 1992).
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The intra- and inter-chain disulfide bonds serve to stabilize folded regions of the nascent
chain and assemble subunits and can form co-translationally. The nascent chain can fold
co- or post-translationally inside the ER (Bergman & Kuehl, 1979; Chen et al., 1995),
and in some cases, assembly begins when the individual chains are still being synthesized
(Bergman & Kuehl, 1979). However, improper intra- and inter-chain disulfide bonds can
form, which can lead to large, insoluble protein aggregates. Folding intermediates that
contain improper disulfide bonds formed during synthesis must undergo isomerization to
achieve the proper conformation. In addition, ER sequesters high concentrations of
calcium, which is required for many signal transduction pathways (Lee, 1987) and clearly
impacts normal protein folding in this organelle. The ER is also a unique environment
for the production and storage of glycogen, steroids, and other macromolecules.
1.6

ER Quality Control and ER Stress

The ER is a crowded environment of newly synthesized, partially folded
polypeptide chains where chaperones and folding enzymes aid and monitor the successful
maturation of secretory pathway proteins through a process termed ER quality control.
This tightly controlled system has set up stringent principals to ensure that only properly
folded protein are delivered out of ER for secretion, while proteins that do not meet these
requirements are quarantined in the ER (Hammond & Helenius, 1995; Ellgaard et al.,
1999). Incompletely folded nascent polypeptide chains in the ER are recognized and
bound by two major molecular chaperone families before they are allowed to leave ER
for the secretory pathway: the Hsp70 family member (BiP), and lectin-like proteins,
calnexin and calreticulin (Ellgaard & Helenius, 2001). The calnexin/calreticulin
chaperones system recognizes the monoglucosylated, N-linked glycans and unfolded
regions on nascent glycoproteins (Sousa et al., 1992; Trombetta & Parodi, 1992;
Hammond et al., 1994). Cleavage of this glucose by glucosidase II (Kornfeld &
Kornfeld, 1985) blocks the binding of calnexin/calreticulin and properly folded proteins
are allowed to leave the ER (Trombetta & Parodi, 1992; Hebert et al., 1995). However,
incompletely folded or mis-folded peptides will be recognized by UDPglucosyltransferase (GT), an ER resident protein, which binds to unfolded regions of the
nascent protein and adds a glucose to a nearby glycan allowing the unfolded substrate to
reenter the cycle (Sousa et al., 1992; Hebert et al., 1995). So this system is dependent on
the presence of both unfolded regions and glycans. The Hsp70 (BiP) chaperone family
recognizes the hydrophobic residues on the unfolded region of nascent peptides (Flynn et
al., 1991; Blond-Elguindi et al., 1993). When N-linked glycosylation is blocked, in some
cases BiP can recognize calnexin/calreticulin substrates (Balow et al., 1995; Zhang et al.,
1997).
Unfolded or misfolded proteins that cannot bury hydrophobic regions by
completing their folding remain associated with these chaperones and are retained in the
ER. Because calnexin is a resident ER integral membrane protein, its binding to
substrates serves to retain them in this organelle. Calreticulin and BiP are soluble
proteins that are themselves kept in the ER due to an ER retention sequence at their Cterminus (Munro & Pelham, 1987). The binding of these molecular chaperones keeps
unfolded proteins in the ER, prevents them from aggregating, and provides them with
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additional opportunities to achieve their correct conformation. Proteins that ultimately
fail to fold and assemble properly are retrotranslocated from the ER to the cytosol for
intracellular degradation by the 26S proteasome (Werner et al., 1996; Hampton, 2002;
Jarosch et al., 2003). The assembly of individually synthesized protein subunits in the
ER is also monitored and regulated by this quality control system.
To deal with changes in the normal environment of ER that affect protein folding
and lead to the accumulation of unfolded or misfolded proteins, ER chaperones and
components of the quality control apparatus are up-regulated to bind and prevent proteins
from aggregating, and provide them with additional opportunities to achieve their correct
conformation. This response is termed unfolded protein response (UPR) which helps to
relieve ER stress. The UPR can be induced by changing cell growth conditions (low pH,
hypoxia, glucose deprivation, and calcium imbalances) or by some pharmacological
reagents that affect ER protein folding (tunicamycin, thapsigargin, and DTT). The UPR
is regulated through the activation of three ER transmembrane stress transducers: IRE1
(Ire1α and β), PERK (PKR-like ER kinase) and ATF6 (Ma & Hendershot, 2004). Under
normal conditions, BiP inactivates all three mammalian UPR transducers by binding to
their lumenal domains. When unfolded proteins accumulate, BiP is released from the
lumenal domains of the transducers. Both IRE1 and PERK dimerize or oligomerize and
are phosphorylated in trans. Ire1α and β contain C-terminal endoribonuclease activity
that is activated during ER stress to splice 26 bases from the XBP-1 (X-box binding
protein) mRNA, which causes a shift in the reading frame of the 3’ end of the mRNA to
generate the active form of XBP-1 (sXBP-1). sXBP-1 protein in turn binds to UPR
elements in the promoters of an number of UPR target genes including ERdj3 (Shen &
Hendershot, 2007), ERdj4 and EDEM ( Lee et al., 2002). The Ire1 pathway is conserved
between yeast and mammalian cells. Ire1p, the yeast homolog, remodels HAC1 mRNA
by the same mechanism (Cox & Walter, 1996). Activated PERK phosphorylates
translation initiation factor eIF-2α, which inhibits cap-dependent translation and therefore
general protein synthesis to reduce the accumulation of unfolded proteins (Harding et al.,
1999). In the case of ATF6, dissociation of BiP allows the protein to be transported to
the Golgi, where the S1P and S2P proteases cleave the membrane-bound ATF6 (90kD),
allows the release of its cytosolic transcription-factor domain from membrane (50kD).
Then the active form of ATF6 is transported to nucleus where it binds and transactivates
ER stress elements found in the promoters of ER chaperones and folding enzymes
(Yoshida et al., 1998; Haze et al., 1999). ATF6 also transcriptionally upregualtes XBP-1
(Haze et al., 1999; Yoshida et al., 2000) which is regulated by Ire1 as described.
1.7

DnaJ Proteins as Specifiers of Hsp70 Function

In a given organelle, DnaJ proteins work with their Hsp70 partner to regulate
multiple functions. The number of DnaJ proteins usually far exceeds the number of
Hsp70s, suggesting that an individual DnaJ may be specific for different functions of
Hsp70. BiP binds to unfolded or incompletely assembled proteins to assist their folding
and assembly as well as to misfolded proteins that need to be degraded. In addition BiP
seals the translocon and regulates the UPR signal transducers. Since BiP has multiple
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functions, it is possible that various ERdjs specify and regulate the different functions of
BiP and perhaps even more ERdjs will be identified.
Many DnaJ proteins can interact directly with unfolded substrates and prevent their
aggregation in vitro. Although in most cases, the substrate binding region has not been
identified, studies on E. coli DnaJ (Banecki, 1996; Szabo, 1996) and the yeast cytosolic
DnaJ proteins, Ydj1 (Li et al., 2003) and Sis1 (Sha et al., 2000), have mapped the peptide
binding region to the C-terminal half of the protein. Although Ydj1 and Sis1 belong to
different classes of DnaJ proteins and the amino acid conservation between them is quite
low, the overall structure was remarkably similar. The substrate binding domain (domain
I) of Ydj1is nearly identical to that found in Sis1, except that in the case of Ydj1, domain
I is bisected in the linear sequence with a Cys-rich domain that folds independently and is
named domain II. The structure of peptide binding fragment of Ydj1(aa 102-384) was
solved with a peptide bound to a hydrophobic face on domain I that was composed of
residues from both the Ia sequence and the Ib sequence.
1.8

Summary

Until now, the substrate binding characteristics of mammalian DnaJ proteins have
been poorly understood. Since ERdj3 interacts with unassembled Ig heavy chains
unusually stably in vivo, it provides a good model to study the interaction between a
mammalian DnaJ protein and unfolded substrate. In our first study, we determined
ERdj3’s secondary structure (ProteinPredict) and modeled its tertiary structure on that of
Ydj1. Using a combination of deletional analysis and point mutations, we characterized
the structural requirements for its binding to substrates by using unassembled HC in in
vivo assays and denatured luciferase in in vitro assays (Chapter 2).
Because we found that ERdj3 was structurally very similar to Ydj1, we further
characterized the structural requirements for in vivo function, by testing the ability of
Ydj1 to function in the mammalian ER using a transient expression system and for ERdj3
to complement yeast that were deficient in either Scj1, the ER DnaJ protein or Ydj1, the
cytosolic family member. Because we found that ERdj3 could compensate the loss of
Ydj1, this allowed us to examine the ability of various structural motifs that we
demonstrated to be important for substrate binding (Chapter 3).
Finally, although the requirements for Hsp70 binding and release have been well
characterized, it has not been clear how DnaJ proteins are released from substrates.
Using a series of ERdj3 and BiP mutants with denatured luciferase as the substrate, we
determined the functional requirements for both BiP and ERdj3 that induce the release of
ERdj3. This allowed us to propose a general model for the release of DnaJ proteins from
substrates (Chapter 4).
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CHAPTER 2. ERDJ3, A LUMENAL ER DNAJ HOMOLOG, BINDS DIRECTLY
TO UNFOLODED PROTEINS IN THE MAMMALIAN ER: IDENTIFICATION
OF CRITICAL RESIDUES
2.1

Introduction

Hsp70 proteins are a family of molecular chaperones found in all organisms and all
organelles. BiP is the mammalian ER Hsp70 homologue and was first identified as an
immunoglobulin heavy chain binding protein (Haas & Wabl, 1983; Bole et al., 1986).
Like other Hsp70s, BiP contains an N-terminal nucleotide binding domain that can
interact with ATP or ADP (Kassenbrock & Kelly, 1989) and a C-terminal substrate
binding domain (Hendershot et al., 1995). The ATPase activity of Hsp70 proteins is
essential for their ability to bind to substrates. In the ATP-bound state, the substrate
binding domain (SBD) is open, which results in both a fast on and off rate for interaction
with unfolded proteins. In the ADP-bound state, the SBD is closed and binds to
substrates slowly but tightly (Liberek et al., 1991). Binding of unfolded proteins to the
SBD stimulates Hsp70’s ATPase activity and induces the hydrolysis of ATP to ADP in
vitro (Flynn et al., 1989). During this process, Hsp70 protein undergoes a
conformational change, which induces closure of a lid over the SBD and stabilizes the
interaction between Hsp70 and the substrate. The release of ADP and rebinding of ATP
resets the Hsp70 to the “open” form, which allows the substrate to be released and to fold
(Munro et al., 1986; Liberek et al., 1991; Buchberger et al., 1995).
The ATPase cycle of Hsp70 proteins is regulated by co-factors that either induce
ATP hydrolysis or regulate nucleotide exchange. DnaJ proteins interact with the ATP
bound form of Hsp70s and induce ATP hydrolysis (Liberek et al., 1990). To date, more
than 100 proteins have been designated as DnaJ-like proteins due to the presence of a
highly conserved ~70 amino acid domain that has been termed the “J domain”. The J
domain contains the signature His-Pro-Asp (HPD) tri-peptide motif, which plays a
critical role in the interaction with Hsp70 (Liberek et al., 1991). Mutation of HPD to
either QPD or HPN abolishes the interaction between the mutant J domain and its Hsp70
partners (Wall et al., 1994; Suh et al., 1998; Tsai et al., 2002). DnaJ proteins can be
divided into three subgroups according to their domain conservation with E. coli DnaJ
(Hennessy et al., 2000). Like E. coli DnaJ, Type I DnaJ proteins contain four domains:
an N terminal J domain, a Gly/Phe-rich flexible linker domain, followed by a Cys-rich
region that forms two Zn2+ binding sites (Banecki et al., 1996; Szabo et al., 1996), and a
C terminal domain that may contain substrate binding motif (Liberek et al., 1990). Type
II DnaJ proteins are similar to type I proteins, except that they lack the Cys-rich region.
Type III DnaJs possess only the J domain, which can be present anywhere in the
molecule. Like Hsp70s, DnaJ proteins exist in all organelles and organisms, but often far
out number the Hsp70s present. Type I and type II DnaJ proteins can interact directly
with unfolded substrates and inhibit protein aggregation in vitro. Studies on E. coli DnaJ
(Banecki et al., 1996; Szabo et al., 1996) and the yeast cytosolic DnaJ proteins, Ydj1 (Li
et al., 2003; Li & Sha, 2005) and Sis1 (Sha et al., 2000), have further defined the peptide
binding region of type I and II DnaJ proteins. Although some Type III DnaJs bind to
substrate directly, like auxilin, which contains a C-terminal J-domain and binds to
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clathrin to assists in the uncoating of clathrin-coated vesicles (Gruschus et al., 2004),
there are no structural data available for any of these family members.
Six mammalian ER localized DnaJ-like proteins have been identified and named
ERdj1-6 (Brightman et al., 1995; Skowronek et al., 1999; Yu et al., 2000; Prols et al.,
2001; Shen et al., 2002; Cunnea et al., 2003; Hosoda et al., 2003; Rutkowski et al.,
2007). ERdj3 is a soluble, lumenal DnaJ family member that binds to unassembled
immunoglobulin heavy chains (HC) along with the BiP chaperone complex in the ER
(Meunier et al., 2002) and with a number of other unfolded proteins that are BiP
substrates (Shen & Hendershot, 2005). The demonstration that the ERdj3 J domain
mutant (HPD→QPD), which abolished its interaction with BiP, did not affect its ability
to bind to substrate (Shen & Hendershot, 2005) led us to hypothesize that ERdj3 might
bind directly to unfolded substrates. Since the interaction between ERdj3 and
unassembled heavy chains is unusually stable in vivo, it was a particularly good model to
investigate the structural features of ERdj3 that are important for substrate binding.
Using secondary structure predictions and tertiary structure modeling, we found that the
C-terminus of ERdj3 is very similar to that of Ydj1 (Li et al., 2003). The domain I
sequence is interrupted with a domain II, although it is much smaller and has an entirely
different sequence than that of Ydj1. Like domain I of Ydj1, it was found to be important
for substrate binding. Mutation of conserved hydrophobic residues in domain I
significantly reduced interaction with substrates in vitro. In addition, we demonstrated
that ERdj3 exists as a dimer in cells and found that Phe326 plays a critical role in
dimerization, which also affected substrate binding. Finally, our data revealed that
domain II was essential for association with γHC and denatured luciferase.
2.2

Materials and Methods

2.2.1 Production of ERdj3 mutants
ERdj3 mutants were made using a Quick Change Site–Directed Mutagenesis PCR
Kit (Stratagene) with wild type HA-tagged ERdj3 (3HA-DSL-ERdj3) and QE-ERdj3
serving as the templates. The QPD mutant was generated previously in our lab (Shen et
al., 2005). Other mutants were generated by PCR using the indicated primer pairs.
∆J: 5’primer GGGGCGGTGATTGCCAAAGATGGTCATCAG and 3’ primer
CTGATGACCATCTTTGGCAATCACCGCCCC
∆G/F: 5’primer GGTGAAGAAGGATTACCTCGTCAGCAAGAC and 3’primer
GTCTTGCTGACGAGGTAATCCTTCTTCACC
∆Ia: 5’primer CATGTTTGGAGGAACCAAGTGCAATTGTCGGC and 3’primer
GCCGACAATTGCACTTGGTTCCTCCAAACATG
∆G/F∆Ia: 5’primer GGTGAAGAAGGATTAAAGTGCAATTGTCGGC and 3’primer
GCCGACAATTGCACTTTAATCCTTCTTCACC
∆II: 5’primer GTTAGAAACAAACCTGTGGCA-CTAGTGAATGAAGAACGAACG
and 3’primerCGTTCGTTCTTCATTCACTAG-TGCCACAGGTTTGTTTCTAAC
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∆IIGSGG:5’primerGTTAGAAACAAACCTGTGGCAGGCAGCGGGGGCCTAGTGA
ATGAAGAACGAACG and 3’primer
CGTTCGTTCTTCATTCACTAGGCCCCCGCTGCCTGCCACAGGTTTGTTTCTAAC
I113A: 5’primer CCAAGAGGAAGTGATGCTATTGTAGATCTAGAAGTC and 3’
primer GACTTCTAGATCTACAATACCATCACTTCCTCTTGG
V132A: 5’ primer GCAGGAAATTTTGTGGAAGCAGTTAGAAACAAACCTGTGG
and 3’ primer CCACAGGTTTGTTTCTAACTCCTTCCACAAAATTTCCTGC
L226A: 5’ primer GTGAATGAAGAACGAACGGCGGAAGTAGAAATAGAGCCTG
and 3’ primer CAGGCTCTATTTCTACTTCCCCCGTTCGTTCTTCATTCAC
F241A: 5’ primer CCTGGAGATTTACGGGCCCGAATCAAAGTTGTC and 3’ primer
GACAACTTTGATTCGGGCCCGTAAATCTCCAGG
F326A: 5’ primer GGGCTCTTTGATAATCACTTTTGATGTGGATGCTCCAAAAGA
ACAG and 3’ primer CTGTTCTTTTGGAGCATCCACATCAAAAGTGATTATCAAA
GAGCCC
F326D: 5’primer GGGCTCTTTGATAATCACTTTTGATGTGGATGATCCAAAAGA
ACAG and 3’primer CTGTTCTTTTGGATCATCCACATCAAAAGTGATTATCAAA
GAGCCC
To generate the ∆III mutant, a PCR reaction was performed using 3HA-DSLERdj3 as the template with 5’EcoRI-CGGAATTCGGACCCGGGAC and 3’NotIATAAGAATGCGGCCGCCAGTGCTTGACAACTTTGATTCGG as primer pairs.
After cutting the PCR product with EcoRI and NotI, it was ligated into the 3HA-DSL
vector in place of the corresponding EcoRI – NotI fragment present in full length ERdj3.
This mutant removes all of domain III as well as the remaining 30 C-terminal amino
acids.
2.2.2 Cell culture, transfection and immunoprecipitation
COS-1 monkey kidney fibroblast cells were maintained in DMEM media
supplemented with 10% fetal bovine serum, 2mM L-glutamine, and 1% Fungisone and
cultured in 3% CO2 at 37 °C. Cells were transfected with the indicated vectors using the
Fugene 6 transfection reagent (Roche Diagnostics), and forty-eight hours posttransfection cells were labeled with 35S Translabel (Amersham Biosciences) for 3h. After
washing with PBS, cells were incubated with 3,3’-dithio-bis (propionic acid Nhydroxysuccinimide ester) (DSP), a membrane permeable cross-linking reagent as
described previously (Meunier et al., 2002a) to stabilize the interaction of ERdj3 with HC.
Cell lysates were prepared using an NP40 lysing buffer and immunoprecipitated with the
indicated antisera followed by binding to Protein A Sepharose beads. The rabbit
polyclonal ERdj3 antibody (Shen et al., 2005) was affinity purified on recombinant
mouse ERdj3 protein for our studies. All the ERdj3 deletion constructs were engineered
with an HA-epitope tag at their C terminus, which can be recognized with an anti-HA
monoclonal antibody (a kind gift of Dr. Albert Reynolds, Vanderbilt University).
Immunoprecipitated complexes were analyzed by SDS-PAGE under reducing conditions,
and the signal was detected using Amplify (Amersham Bioscience) for autoradiographic
visualization.
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2.2.3 Protein purification
The expression of His-tagged wild-type and mutant ERdj3 proteins were induced in
E. coli M15 cells with 0.1 mM isopropyl β-D-thiogalactoside (Sigma) followed by
growth for 18 h at 18°C. The recombinant proteins were purified on Ni2+-agarose
columns under non-denaturing conditions (Qiagen QIAexpress system), dialyzed in
25mM sodium phosphate buffer (pH 7.0) containing 150mM NaCl, 0.02% Triton X-100,
50% glycerol, and a protease inhibitor cocktail (Roche), and stored at -20°C.
2.2.4 Measurement of complex formation between ERdj3 proteins and denatured
luciferase
Wild type or mutant ERdj3 recombinant proteins (0.5μg in 100 μl of PBS
containing 0.05% BSA) were added to each well of a 96-well microtiter plate purchased
from Theromo (Immulon 2HB Flat Bottom Microtiter Plate) and allowed to bind
overnight at 4ºC. Wells were washed three times with PBS to remove unbound ERdj3
and blocked with 200μl PBS containing 1% BSA for 1h at room temperature. Firefly
luciferase was denatured in buffer containing 7M Urea, 25mM HEPES (pH 7.5), 50mM
KCl, 5mM EDTA, 5mM MgCl2, and 5mM dithiothreitol at room temperature for 40 min
and then diluted into PBS containing 0.05% BSA (final concentration 5 µg/ml). 100 μl
of this solution was added to the wells containing wild type or mutant ERdj3 and allowed
to bind for 1hr at room temperature followed by washing with PBS to remove unbound
luciferase. The amount of denatured luciferase that remained bound to ERdj3 was
detected with a polyclonal anti-luciferase antiserum followed by donkey anti-rabbit Ig
conjugated to alkaline phosphatase (Promega). The substrate 4-Nitrophenyl phosphate
disodium salt hexahydrate (Sigma) was added to the wells for approximately 10 min, and
then 0.75 M NaCl was added to stop the reaction. The plates were read on a
spectrophotometer (BioRAD) at wavelength 405nM. Negative controls were included
for each plate in wells that did not contain either denatured luciferase, ERdj3, or each of
the antibodies, but which included all the other steps of the reaction. The amount of DLuc that bind to WT ERdj3 was set as 100%, the amount of D-Luc bound to indicated
forms of mutants were set as percentage of WT.
2.3

Results

2.3.1 Modeling ERdj3’s secondary structure
We have recently demonstrated that ERdj3 can bind directly to free HC and
denatured luciferase in vitro (Jin et al., submitted). To begin to characterize the regions
of ERdj3 that contribute to substrate binding, we first used a computer program
(Predictproteins) to generate a secondary structure prediction for ERdj3 and compared it
with those of two yeast cytosolic DnaJ proteins for which structural data are available for
the protein binding domain, Ydj1 (type I DnaJ subgroup) and Sis1 (type II DnaJ
subgroup) (Sha et al., 2000; Li et al., 2005). Although the amino acid sequences of these
18

two proteins are not highly conserved, their overall secondary (Figure 2-1A) and tertiary
structures are very similar, except that Sis1 lacks the cysteine-rich domain II, which is a
hallmark domain of type I DnaJ proteins. Comparison of the secondary structure
predictions revealed that ERdj3 is likely to be more similar to Ydj1, in that it appears to
have an additional sequence (domain II) inserted within domain I (Figure 2-1A).
However, the sequence and size of this domain is quite different from that of Ydj1
(Figure 2-1A & B). The corresponding domain in Ydj1 is 65 amino acids in length, with
8 cysteine residues that form two zinc binding centers (CXXCXG motif), whereas the
predicted domain in ERdj3 is only 40 amino acids in length and possesses only four
cysteine residues that form two intradomain disulfide bonds (Shen et al., 2005; Marcus et
al., 2007). Using PyMol (DeLano Scientific LLC ) to model the structure of ERdj3 in
this region, we found that domains I and III of these two molecules appeared to be almost
identical, whereas domain II could not be modeled on the structure of Ydj1 (data not
shown).
2.3.2 Mapping ERdj3’s substrate binding domain in vivo
Based on the crystal structures of Ydj1 and Sis1 and our ability to model ERdj3 on
the Ydj1 structure, we defined domain boundaries for ERdj3 and referred to them as
domain I (Ia and Ib), II and III and made corresponding deletion mutants (Figure 2-2A).
In addition, we deleted the J domain, the Gly/Phe-rich domain alone, and the Gly/Pherich domain along with domain Ia to investigate the role of each of these domains in
substrate binding. The HA-epitope tag that is encoded at the carboxyl terminus of each
of these mutants ensured our ability to immunoprecipitate each of them. For domain III,
we removed the sequence that was predicted to form this domain, as well as the
remaining 30 amino acids at the carboxy-terminus. Domain Ia and Ib were deleted
separately, even though the structural predictions suggest that they should fold together to
form an intact domain I. In the case of domain II, two deletion mutants were made, one
that removed only the sequence encoding this domain (ΔII) and a second one in which
domain II was replaced by a four amino acid flexible linker, GSGG, to increase the
possibility that the two halves of domain I would fold correctly in the absence of domain
II (Figure 2-2A). Each of the ERdj3 constructs was first expressed in COS cells alone.
SDS-PAGE analysis revealed that all of the proteins were expressed and could be
immunoprecipitated with the anti-HA antibody (Figure 2-2C). Importantly none of these
proteins bound non-specifically to Protein A Sepharose beads (Figure 2-2C). The ERdj3
constructs were next co-expressed with HC, and an attempt was made to normalize the
expression of the various mutants. To determine the ability of the various ERdj3 proteins
to associate with HC, cells were treated with DSP, which is required to stabilize ERdj3’s
association with γHC (Meunier et al., 2002), and then co-immunoprecipitation assays
were performed with the indicated antibodies (Figure 2-2B). The presence of HC, BiP,
and GRP94 in the anti-HA lanes is not meaningful, as the HC bind directly to Protein ASepharose and co-precipitate these two chaperones. When each of the lysates was
immunoprecipitated only with Protein A beads to isolate HC, we found that wild-type
ERdj3 was co-precipitated as expected (Figure 2-2B). Examination of each of the
mutants revealed that deletion of the J domain (J) actually increased the binding of this
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Figure 2-1.

Structural comparisons of the DnaJ proteins

(A) Secondary structure predictions for Ydj1, Sis1, and ERdj3. Colors represent the
different domains: Light grey: ER targeting sequence; Grey: J domain; Bold and Italics:
domain I; Bold and underlined: domain II, and Black: domain III. H: α helix and E: β
sheet. (B) Shematic of domain boundaries for Ydj1, Sis1 and ERdj3. Sis1does not
contain cysteine-rich domain II found in Ydj1. ERdj3 is more similar to Ydj1, although
it contains an atypical, smaller domain II.
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Figure 2-2.
HC in vivo

Determination of the ability of wild-type and mutant ERdj3 to bind

(A). A schematic drawing of the domain structure of the various mutants. In the case of
one of the domain II mutants, a GSGG linker was added between domain Ia and Ib to aid
in keeping the protein structure intact. (B). COS cells were cotransfected with HC and
either WT ERdj3 or the indicated ERdj3 mutants and metabolically labeled proteins were
immunoprecipitated as indicated. Samples were analyzed by reducing SDS-PAGE. (C).
COS cells were transfected with each of the ERdj3 constructs alone and analyzed as in
(B).
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mutant to γHC, which is consistent with our previous finding that mutation of the HPD
motif in this domain resulted in better binding of mutant ERdj3 with several different
substrate proteins in cells (Shen et al., 2005). Deletion of the Gly/Phe-rich region (ΔG/F)
did not obviously affect binding to HC, and removing domain III only had a very
modest effect on binding. When domain Ia was deleted alone or along with the Gly/Pherich region, we observed a slight decrease in the ability of the mutant proteins to associate
with the substrate. Structural data on Ydj1 revealed that domain I is in direct contact
with a peptide that was co-crystallized with Ydj1 and therefore is very likely to form at
least part of the substrate binding site (Li et al., 2005). Domain I of Sis1 also contains a
similar substrate binding structure based on crystallographic data (Sha et al., 2000; Li et
al., 2003; Li et al., 2006). Somewhat unexpectedly, we found that deletion of domain II
(∆II), which bears little homology to the corresponding domain in Ydj1 and is missing in
Sis1, had the most dramatic effect on HC binding.
2.3.3 Binding of ERdj3 to purified denatured luciferase in vitro
A caveat to these data is that binding of even wild-type ERdj3 to γHC in cells can
only be detected with a chemical cross-linker due to the detergent sensitive nature of its
association with substrates (Meunier et al., 2002), and the effects of most of the deletions
are quite modest. Using PyMol (DeLano Scientific LLC) to model ERdj3 structure, we
identified the residues that could potentially form the substrate binding patch in domain I
of ERdj3. The model indicates that these hydrophobic residues are highly conserved
between ERdj3 and Ydj1, suggesting that ERdj3 forms same substrate binding motif as
Ydj1 (Figure 2-3A). Since we recently demonstrated that ERdj3 could bind to
chemically denatured luciferase in solution and in a modified ELISA assay (Jin et al.,
submitted), we used this assay to further probe the regions of ERdj3 required for
substrate binding. Similar to data obtained for the in vivo binding of the various mutants
to γHC, we found that deletion either domain Ia or II significantly diminished ERdj3’s
ability to bind to D-Luc (Figure 2-3B). According to structural data for Ydj1 and Sis1,
domain I contains a hydrophobic pocket that forms the substrate binding site (Sha et al.,
2000; Li et al., 2003). Deletion of domain Ia is likely to distort the overall structure of
this domain, since it cooperates with domain Ib to form the intact domain I. Thus data
obtained with this mutant cannot be clearly interpreted. When we aligned the structural
model of ERdj3 with Ydj1, we found that four out of five amino acids in Ydj1’s domain I
that form the hydrophobic pocket were conserved in ERdj3 (Figure 2-3C). To examine
the roles of these amino acids in ERdj3’s ability to bind substrate, we mutated each of
these four amino acids alone (I113A, V1332A, L226A, F241A), the first two amino acids
together (I113A-V132A), or all of them together (IVLF-A) to alanine and tested their
ability to bind to D-Luc in vitro. We found that except for I113A, all of the point
mutations or combinations of them affected ERdj3’s ability to bind to D-Luc (Figure
2-3C). This suggested that these hydrophobic amino acids are likely to also form the
substrate binding site in ERdj3, which agrees with the structure model (Figure 2-3A).
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Figure 2-3.
to D-Luc

Both domain I and domain II of ERdj3 contribute to its ability to bind

(A) Ribbon diagram of the modeled structure of domain I of ERdj3 (left) showing amino
acid residues that could potentially form the hydrophobic substrate binding patch
described for Ydj1. An overlap of the substrates binding motifs of ERdj3 and
Ydj1(right). Grey: substrate peptide; Green: Ydj1; Pink: ERdj3; Red: residues on Ydj1
that interacted with substrate; Blue: corresponding residues on ERdj3. (B) Measurement
of complex formation between wild type and mutant ERdj3 and denatured luciferase.
The quantity of luciferase bound to WT ERdj3 was set as 100% of control, and the values
for the mutants were expressed as a percentage of wild type ERdj3. (C) Measurement of
complex formation between wild type ERdj3 and point mutants and denatured luciferase.
Relative binding was determined as in (B).
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2.3.4 ERdj3 forms dimer, which is important for substrate binding
The yeast cytoplasmic DnaJ homologues, Ydj1 and Sis1, form dimers via
sequences located in their C terminus, which are essential for substrate binding (Sha et
al., 2000; Wu et al., 2005). Since ERdj3 is similar to Ydj1 in overall structure, we tested
whether ERdj3 forms dimers in cells. First, we made a 3×HA-ERdj3 construct, which
contains three HA tags at the C terminus of ERdj3 in order to clearly separate it from the
untagged versions of ERdj3. Each of tagged and untagged constructs were first
expressed in COS cells alone. Cell lysates were prepared and immunoprecipitated with
Protein A Sepharose beads alone, the anti-ERdj3 serum, or a monoclonal anti-HA
antibody. The monoclonal anti-HA antibody interacted only with HA-tagged form of
ERdj3, whereas the polyclonal anti-ERdj3 recognized both 3HA-ERdj3 and ERdj3
(Figure 2-4A). The 3X HA-tagged form of ERdj3 was readily distinguished from ERdj3
on 10% SDS-PAGE gels. Next, the 3×HA-tagged form of ERdj3 was co-expressed with
untagged wild-type ERdj3. We observed that the anti-HA antibody precipitated both
3×HA-ERdj3 and ERdj3 at an approximately 1:1 ratio when they were co-expressed
(Figure 2-4B lane 6), suggesting that 3× HA-ERdj3 and ERdj3 are associated with each
other in cells as either dimers or multimers. Unlike ERdj3’s association with substrate,
ERdj3 dimers are stable in the presence of detergents and can be detected in the absence
of crosslinker.
It has been reported that tyrosine (Y) 336 on Sis1 plays an important role in
dimerization (Sha et al., 2000). Phenylalanine (F) 335 of Ydj1 is the counterpart of Y336
of Sis1 and is also critical for Ydj1 dimerization (Li et al., 2005; Wu et al., 2005).
Sequence alignment of Sis1, Ydj1 and ERdj3 identified F326 on ERdj3 as the likely
counterpart of F335 of Ydj1 and Y336 of Sis1. Thus, we mutated F326 to either alanine
(A) or aspartic (D) amino acid on both an untagged or HA-tagged background. The
indicated mutants were first expressed in COS cells and immunoprecipitated with either
Protein A Sepharose beads alone, the anti-ERdj3 serum, or a monoclonal anti-HA
antibody. All of the proteins were expressed and migrated to the expected position on the
SDS-gels. HA-tagged ERdj3 constructs were recognized by both anti-ERdj3 and antiHA antibody, whereas the untagged forms were only precipitated by anti-ERdj3
antibody. None of them bound to Protein A Sepharose beads nonspecifically. To
examine whether ERdj3 F3326A/D form dimers with wild type ERdj3, HA-tagged wild
type ERdj3 was co-expressed with the untagged F326A or F326D ERdj3 mutants and
immunoprecipitation experiments were performed (Figure 2-4B lane 7-12). We found
that untagged F326A/D was not co-precipitated along with HA-tagged wild type ERdj3
when it was precipitated with the anti-HA antibody, demonstrating that the F326A/D
mutations affected the ability of ERdj3 to form dimers. We also co-expressed untagged
F326A/D ERdj3 along with HA-tagged F326A/D ERdj3 (Figure 2-4B lane 13-18).
Again, we found that the mutation of F326 to either alanine or aspartic acid abolished
ERdj3’s ability to forms dimers.
The ability of F326D ERdj3 to bind to denatured luciferase was next examined. We
found that this mutation decreased the binding of ERdj3 to D-Luc, as did deletion of
domain III (ΔIII), which lacks the dimerization residue (Figure 2-5). The fact that
dimerization mutants (F326A/D and ΔIII) diminished the ability of ERdj3 to bind to
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Figure 2-4.

ERdj3 forms dimers in cells

COS cells were transfected with cDNA encoding pSG-ERdj3 (lane1-3), 3×HA-ERdj3
(lane 4-6) (with HA epitope tagged at its C-terminus), ERdj3 F326A (lane 7-9), F326D
(lane 13-15), HA-ERdj3 F326A (lane10-12) and HA-ERdj3 F326D (lane 16-18) either
alone (A) or co-transfected with 3×HA-ERdj3 (B). Metabolically labeled cell lysates
were divided into three equal parts and incubated with indicated antibodies. Samples
were analyzed by reducing SDS-PAGE.
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Figure 2-5. Deletion of domain III or mutation of Phe326 to aspartic acid affects
ERdj3’s substrate binding ability.
ELISA assay for luciferase binding was performed and quantitated as described in Figure
2-3B.
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substrate strongly argues that dimerization is important for ERdj3’s substrate binding,
which is consistent with what has been reported for Ydj1 and Sis1 (Wu et al., 2005).
2.4

Discussion

According to their domain conservation with E. coli DnaJ, DnaJ proteins have been
divided into three subgroups. Type I and II DnaJ proteins appear to bind directly and
promiscuously to the unfolded regions of multiple substrates through their substrate
binding domain, whereas type III proteins either do not bind to unfolded proteins or have
a very limited client repertoire. A crystal structure has been obtained for the C terminal
fragment of Ydj1 (102-384 aa) with a bound peptide (GWLYEIS) (Li et al., 2003). This
fragment lacks both the N terminal J domain and G/F rich flexible linker and contains a
mutation of phenylalanine 335 to aspartic acid, which disrupts its ability to form dimers
(Li et al., 2003). The structure revealed that the peptide bound to a hydrophobic pocket
on domain I and made contact with five different polar residues in this pocket. The
importance of these residues in binding to peptide was confirmed with mutagenesis
studies (Li et al., 2005). The structure of the corresponding C terminal region of Sis1 had
been solved previously, but in this case there was no substrate bound (Sha et al., 2000).
Although the amino acid sequence homology is not high between these two proteins in
this region, their tertiary structures were nearly identical, except that Sis1 lacks the Cysrich domain II (Li et al., 2003), suggesting that domain I of Sis1 is likely to contain the
substrate binding site. This possibility was supported by mutagenesis studies in which
mutations in the hydrophobic pocket affected Sis1’s ability to bind substrate (Lee et al.,
2002). Our data revealed that ERdj3 should be considered to be a type I DnaJ protein
even though its domain II is quite different from that of Ydj1. We found that most of the
hydrophobic amino acids that form the substrate binding site on Ydj1 are conserved in
ERdj3. Mutations of these amino acids alone or in combination affected ERdj3’s ability
to bind to D-Luc in vitro. Overall these studies suggest that this substrate binding
structure may be common to all type I and II DnaJ proteins. This possibility is further
supported by earlier peptide binding studies on DnaJ (Rudiger et al., 2001), where it was
found that DnaJ preferred to bind peptides with hydrophobic features.
Type I and II DnaJ proteins form homodimers, and the dimerization motif is
located in the C terminus of these proteins (domains III and II respectively). Both Ydj1
and Sis1 dimerize via a number of hydrophobic residues that form a hydrophobic patch.
Mutation of F335 of Ydj1 to aspartic acid disrupted the hydrophobic patch and yielded
monomers (Li et al., 2005). In the case of Ydj1, residues in β-strands in domain III of
one monomer can interact with those of another monomer to contribute to homodimer
formation (Wu et al., 2005). Disruption of dimer formation for both Ydj1 and Sis1
results in severe defects in their ability to bind to substrates and to facilitate Hsp70’s
ability to refold substrates (Wu et al., 2005). We demonstrated that ERdj3 forms dimers
or multimers in cells. Our in vivo study revealed that the F326A/D mutation abolished
ERdj3’s ability to form dimers. Similar to data obtained with Ydj1, this affected ERdj3’s
ability to interact with substrates. This finding supports a model where the dimerization
of both type I and II DnaJ proteins allows the two substrate binding domains to form a
clamp around unfolded substrates (Landry, 2003). Although type III DnaJ proteins are
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much less conserved, some of them have been shown to have substrate proteins
(Gruschus et al., 2004). Although it has not been examined, it is possible that this group
of proteins does form dimers or conversely that dimerization is more important for the
ability to interact with a broader range of substrates, which is a hallmark of the type I and
II DnaJ proteins.
Our in vivo assay to examine the binding of ERdj3 mutants with HC revealed that
the ΔIII ERdj3 mutant, which lacked the dimerization domain, bound to HC as well as
WT ERdj3, whereas in the in vitro assay, the association of the ΔIII ERdj3 with D-Luc
was significantly diminished. We can think of four possibilities to account for this,
which are not mutually exclusive. First, in the in vivo assays, a crosslinker was used,
which could serve to stabilize transient interactions between ERdj3 and the substrate.
Second, since a number of chaperones form a complex in the ER of cells, which includes
BiP (Meunier et al., 2002), it is possible that the substrate is binding to one of these and
not to the ΔIII ERdj3 mutant directly. Third, although deletion of domain III or mutation
of F326 to alanine or aspartic acid disrupted dimer formation, the use of crosslinking
agents revealed that some dimers could be still be detected with these mutants (data not
shown). Thus, it is conceivable that the use of crosslinker might stabilize the interaction
between the ΔIII mutant and endogenous ERdj3, which would result in the apparent
association of ΔIII with HC in vivo. Finally, it is possible that the differences we are
observing in the in vivo versus in vitro assay are actually reflecting distinct affinities of
ERdj3 for these two substrates.
Our results argue that domain II is critical for ERdj3’s substrate binding ability.
This Cys-rich region in other type I proteins contributes to their chaperone activities by
affecting the transfer of substrate to the Hsp70 partner (Lu et al., 1998). Previously we
reported that ERdj3 contains intra-chain disulfide binds (Shen et al., 2005). Only four
cysteines are found in ERdj3, and they are all in domain II, arguing that they are
responsible for the intra-chain disulfides and do not form a zinc-finger binding site as in
other type I DnaJ proteins, which was confirmed by recent studies (Marcus et al., 2007).
Although domain II of ERdj3 is very different from that of Ydj1, it is very highly
conserved among ERdj3 proteins in different species (about 80% identity between human
and C. elegans). However, Sis1, which possesses a very a similar overall substrate
binding structure as Ydj1, does not possess a domain II. Of interest, the structure of the
Ydj1 C-terminal fragment could only be obtained with a bound peptide, whereas Sis1’s
was crystallized without the presence of a peptide. Considering these facts, we propose
that domain II could play a role in stabilizing domain I of type I DnaJ proteins in the
absence of substrate. Alternatively is it possible that the substrate binding repertoire of
type I proteins is different than that of type II DnaJ proteins and therefore requires a more
complex binding site. But the fact that both Ydj1 and Sis1 binds to denatured luciferase
in vitro argues against this possibility.
In summary, we have demonstrated that domain I and II of ERdj3 contribute to
substrate binding. The hydrophobic residues in domain I of ERdj3 apparently form a
substrate binding site that resembles that of Ydj1. The role of domain II is less clear but
could be important in maintaining domain I in a configuration that is critical for substrate
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binding. In addition we found that ERdj3 exists as a dimer in cells, which contributes to
substrate binding. Together these data help to define the structural elements required for
substrate binding for DnaJ proteins.
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CHAPTER 3. FUNCTIONAL CONSERVATION BETWEEN ERDJ3 AND YDJ1,
DNAJ HOMOLOGUES IN THE MAMMALIAN ER AND YEAST
CYTOPLASM
3.1

Introduction

Hsp70 proteins constitute a highly conserved group of molecular chaperones that
are found in all organisms and all cellular organelles. They play critical roles in most
cellular functions due to their ability to bind to unfolded regions on nascent proteins or
subunits of heteromeric complexes in a nucleotide-dependent manner (Munro & Pelham,
1986; Liberek et al., 1991; Buchberger et al., 1995). The ATPase activity of Hsp70
proteins is tightly regulated by DnaJ proteins that increase the hydrolysis of ATP leading
to enhanced binding of the Hsp70s to substrates (Liberek et al., 1991) and nucleotide
exchange factors that release them (Liberek et al., 1991; Chung et al., 2002). Some DnaJ
proteins bind directly to unfolded regions on substrate proteins through their substrate
binding domain and serve to recruit the ATP-bound form of their Hsp70 partner to the
unfolded substrate (Rudiger et al., 2001). The number of DnaJ proteins in most
organisms/organelles far exceeds that of Hsp70s. A single Hsp70 can interact with
multiple DnaJ proteins and form unique DnaJ/Hsp70 pairs (Caplan et al., 1993;
Cheetham & Caplan, 1998; Sahi & Craig, 2007). This has led to the hypothesis that
different DnaJ proteins selectively interact with their Hsp70 partner and regulate its
specific functions.
DnaJ proteins regulate the ATPase activity of their Hsp70 partner via direct
interaction with the nucleotide binding domain, which occurs through a highly conserved
~70 amino acid J domain (Wall et al., 1994). J domains contain a signature tri-peptide
HPD (Histidine-Phenylalanine-Aspartic acid) motif, which is critical for inducing
Hsp70s’ ATPase activity (Wall et al., 1994; Tsai & Douglas, 1996). In many cases DnaJ
proteins are not interchangeable between organelles or organisms even though the J
domains are highly conserved. This suggests that there is some specificity between
DnaJ/Hsp70 pairs; at the level of substrate recognition, the ability to functionally interact
with the particular Hsp70, or the ability to fold appropriately within a given organelle. A
recent genetic study was conducted to test the ability of 13 different yeast cytosolic DnaJ
proteins to functionally interact with resident Hsp70s (Sahi & Craig, 2007). It was found
that in many cases the ability to stimulate the ATPase activity of a particular Hsp70 was
sufficient to constitute a functional pair. However, specific features of DnaJ proteins,
such as the ability to interact with substrates, can also be required (Johnson & Craig,
2001).
ERdj3 is a mammalian ER type I DnaJ family member, which binds to unfolded
substrates (Yu et al., 2000; Meunier et al., 2002; Shen et al., 2005). The structural
features of ERdj3 that contribute to substrate binding were found to closely resemble
those of Ydj1 (Chapter 2). In addition to identifying the hydrophobic residues in domain
I that are likely to form the substrate binding site, it was found that ERdj3 dimerizes,
which significantly enhances substrate binding. Somewhat unexpectedly, it was
ascertained that domain II of ERdj3, which is significantly different from the domain II in
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other type I DnaJ proteins, including Ydj1, was most important for substrate binding.
The identification of critical features for substrate binding encouraged us to attempt to
establish their roles in vivo using yeast complementation studies and to probe the
requirements for establishing functional Hsp70/DnaJ pairs.
We found that Ydj1 bound to BiP and ERdj3 substrates when it was expressed in
the mammalian ER. The reciprocal experiment was employed to determine whether
ERdj3 could be functional in yeast. A cytosolically expressed, ER membrane tethered
form of ERdj3 rescued the slow growth phenotype of the hlj1∆ydj1-151 mutant strain,
while the ERdj3 mutations that affected substrate binding did not. Perhaps most
surprisingly, deletion of domain II also inhibited complementation even though domain II
of ERdj3 is much smaller and has a very different sequence than that of domain II of
Ydj1. Expression of ERdj3 in the yeast ER did not rescue the growth defect of yeast
containing mutations in two lumenal DnaJ homologs, SCJ1 and JEM1. This was likely
due to the inability of ERdj3 to stimulate the ATPase activity of yeast BiP/ Kar2p, the ER
lumenal Hsp70. Our studies provide further insights into requirements for producing
functional Hsp70/DnaJ pairs and argue that in addition to requirements for functional
interactions between these two proteins, the substrate binding properties of DnaJ proteins
might be critical to specify the in vivo function of chaperone pairs.
3.2

Materials and Methods

3.2.1 Preparation of Ydj1 and ERdj3 constructs
To express Ydj1 in the mammalian ER, PCR was used to engineer an ER-targeting
signal-sequence onto the N-terminus of Ydj1 using pBS-Ydj1 as a template. Primer pairs
include:
5’ primer: CGGGATCCatggctccgcagaacctgagcaccttttgcctgttgctgctatacctcatcggg
gcggtgattgccGTTAAAGAAACTAAGTTTTACGATATTCTAGGTGTTCC and 3’
primer: CGGGATCCTCATTGAGATGCACATTGAACACCTTC.
The lower case letters represent the inserted ER targeting signal sequence and the italics
indicate a BamHI site. The PCR product was digested with BamHI and inserted into
3HA-DSL mammalian expression vector. The translation stop codon in the 3HA-DSLssYdj1 construct was destroyed using the Quick change site-directed PCR kit
(Stratagene) with the following primers.
5’ primer: GAAGGTGTTCAATGTGCATCTCAAGGATCCCCGGAATTCCTCGAG
3’ primer: CTCGAGGAATTCCGGGGATCCTTGAGATGCACATTGAACACCTTC
The resulting PCR product has an HA tag at the C-terminus, which was already present in
the 3HA-DSL vector. A Kozak sequence (underlined) was inserted at the translation start
site of 3HA-DSL- ssYdj1 using Quick change PCR kit with the following primers:
5’primer:GTTTAAACGGATCCACCCGGGACAGAGGAACCATGGCTCCGCAGAA
C and 3’primer:GTTCTGCGGAGCCATGGTTCCTCTGTCCCGGGTGGATCCGTTTA
AAC
A construct that would produce a soluble luminal form of Ydj1 (ssYdj1 C406S) was
generated by mutating the C terminal farnesylation site with the primer pair:
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5’ primer: GGTGGCGAAGGTGTTCAAAGTGCATCTCAAGGATCCCCG and 3’
primer: CGGGGATCCTTGAGATGCACTTTGAACACCTTCGCCACC
To express ERdj3 in yeast, two constructs were produced under the control of the
GPD promoter in the multi-copy pGPD426 vector. Full length ERdj3 containing a signal
sequence for luminal ER expression was made by PCR using 3HA-DSL-ERdj3 vector as
the template with the following primer pair:
5’ primer: CGGAATTCGGACCCGGGAC
3’ primer: CGGGATCCATATCCTTGCAGTCCATTGTATACCTTCTG
The resulting PCR product was digested with EcoRI and BamHI and inserted into the
pGPD426 yeast expression vector (pGPD-ERdj3). For cytosolic expression at the ER
membrane, CaaX-ERdj3 was generated using the following primer pair with 3HA-DSLERdj3 serving as the template:
5’ primer: CGGGATCCGGAACCATGGGACGAGATTTCTATAAGATCTTGGGG
3’ primer: CCCAAGCTTTCATTGAGATGCACATTGCAGTCCATTGTATACCTTC
TGC
The resulting PCR product lacked the N-terminal signal sequence, and the C-terminal GY
was replaced with a “CaaSQ” farnesylation sequence. The PCR product was digested
with BamHI and HindIII and subcloned into the pGDP vector (pGDP-CAAX-ERdj3) to
allow it to be expressed in yeast. All mutants were generated by QuickChange PCR with
the primer pairs previously described (Chapter 2).
3.2.2 Expression and detection of Ydj1 in mammalian cells
Cells were transfected with the indicated vectors using the FuGENE 6 transfection
reagent (Roche). After 48 hours, cells were labeled with 35S Translabel (Amersham
Biosciences) for 3h, and cell lysates were prepared as described previously (Jin et al.,
submitted). To stabilize complexes between the various DnaJ-like proteins and either
BiP or substrate, cells were treated with 150 μg/ml 3,3’-dithio-bis (propionic acid Nhydroxysuccinimide ester: DSP) for 1h on ice and lyzed in NP40 lysing buffer after
quenching with 100 μl of 1M glycine. Solubilized proteins were incubated with the
indicated antisera followed by precipitation with Protein A Sepharose beads. The
immunoprecipitated complexes were subjected to SDS-PAGE and analyzed under
reducing conditions. The signal was enhanced using Amplify (Amersham Bioscience)
and detected by autoradiography.
3.2.3 Protein expression, purification and ATPase assay
His-tagged recombinant murine ERdj3 (wild type and mutants) and hamster BiP
proteins were expressed in E. coli M15 cells and purified under non-denaturing
conditions using Ni2+-agarose (Qiagen QIAexpress System) as described (Jin et al.,
submitted). Briefly, ERdj3 proteins were induced with 0.1 mM isopropyl β-Dthiogalactoside (Sigma) followed by growth for 18 h at 18°C, whereas the BiP protein
was induced with 1mM IPTG at 37°C for 2hrs. ERdj3 recombinant proteins were stored
at -20°C in 25 mM sodium phosphate buffer containing 150mM NaCl, 0.02% Triton X32

100, 50% glycerol and Complete EDTA-Free Protease inhibitor cocktail tablet (Roche).
BiP protein was stored in 20mM HEPES buffer (pH 7.2) with 50mM KCl, 5mM MgCl2,
0.01% NP-40, 50% glycerol, and Complete EDTA-Free Protease inhibitor cocktail tablet.
3.2.4 ATPase assays
The following proteins were purified using previously established protocols: Ssa1p
(McClellan et al., 1998), Ydj1p (Cyr et al., 1992), GST-tagged J-domain of Hlj1p
(Youker et al., 2004), hexahistidine-tagged yeast BiP/Kar2p (McClellan et al., 1998), and
the GST-tagged J-domain of Sec63p (Corsi & Schekman, 1997). Steady-state ATPase
assays using the indicated molar ratios of DnaJ protein to Hsp70 were performed as
described (Cyr et al., 1992; McClellan et al., 1998).
3.2.5 Rescue of the slow growth phenotype of the Ydj1 mutant strain
The following Saccharomyces cerevisiae yeast strains were used for
complementation studies: HLJ1 YDJ1 (MAT ade2-1 leu2-3,112 his3-11,15 trp1-1 ura31 can1-100), hlj1 ydj1-151 (MAT ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1100 hlj1::TRP1 ydj1-2::HIS3 LEU2::ydj1-151) (Youker et al., 2004), SCJ1 JEM1
(MAT lys2-801 leu2-3,112 his3-200 trp1-901 ura3-52 suc2-9) and scj1 jem1
(MAT ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100 scj1::TRP1
jem1::LEU2) (Nishikawa & Endo, 1997). The yeast strains were grown to logarithmic
phase at 26°C in yeast extract–peptone–dextrose medium containing 2% glucose and
transformed with the indicated plasmids using lithium acetate (Ito et al., 1983). The
resulting transformants were selected and grown to logarithmic phase at 26°C in
synthetic complete medium containing 2% glucose. 10-fold serial dilutions were spotted
onto solid medium and cultured at the indicated temperatures for 2 days.
3.3

Results

3.3.1 Ydj1 expressed in the mammalian ER binds to BiP and ERdj3 substrates
We found that the mammalian ER localized DnaJ orthologue, ERdj3, appears to be
structurally very similar to Ydj1, a yeast cytosolic DnaJ protein (Chapter 2) with the
exception of domain II, which was demonstrated to be important for substrate binding
(Figure A-1). To better understand restrictions guiding Hsp70/DnaJ pairs, mammalian
BiP was co-expressed in COS cells with a C-terminal HA-tagged ERdj3 or two different
Ydj1 constructs engineered with an N-terminal ER signal-sequence and a C-terminal HA
tag. In one construct, Ydj1’s farnesylation site was removed (ssYdj1C406S) and the
other retained it (ssYdj1). Both can be expressed in mammalian ER (Figure A-2). To
determine their ability to associate with BiP, ssYdj1 or ssYdj1 C406S and BiP were coexpressed in COS cells. Forty-eight hours post-transfection, cells were metabolically
labeled and treated with DSP to stabilize BiP: DnaJ protein interactions (Meunier et al.,
33

2002). ERdj3 and BiP were co-expressed as a positive control for association. Coimmunoprecipitation experiments revealed that both Ydj1 proteins could associate with
BiP as well as ERdj3 did (Figure 3-1A), regardless of whether the complex was detected
with an anti-BiP or an anti-HA monoclonal antibody that recognized the epitope tag on
the DnaJ proteins. Neither of the Ydj1 proteins bound nonspecifically to Protein-A
Sepharose beads.
The ability of Ydj1 to bind to an immunoglobulin κ light chain (κLC), which is a
substrate of both BiP and ERdj3 (Shen et al., 2005) was examined. Cells were cotransfected with constructs encoding κLC along with either ERdj3 or ssYdj1. It was
found that ssYdj1 associated with κLC as efficiently as ERdj3 (Figure 3-1B). The fact
that an ER expressed form of Ydj1 could interact with both BiP and κLC suggested that
Ydj1 was likely to be functional in the ER of mammalian cells. This led to the possibility
that ERdj3 might be functional in yeast.
3.3.2 Overexpression of ERdj3 does not rescue the temperature-sensitive defect of the
Δscj1Δjem1 strain
Because ERdj3 is an ER localized protein that contains intra-chain disulfide bonds,
its ability to function in the yeast ER was tested first. Scj1 and Jem1 are two yeast ER
DnaJ proteins that interact with Kar2p, the yeast ER Hsp70 (Schlenstedt et al., 1995).
They are required for multiple ER functions including protein folding in the yeast ER and
ER associated degradation (ERAD) (Nishikawa et al., 2001). Because Scj1 has a similar
apparent molecular weight as ERdj3 and is also a soluble protein, it has been suggested to
be the homolog of ERdj3 (Figure A-1). Loss of both Scj1 and Jem1 (Δscj1Δjem1)
induces the unfolded protein response (Nishikawa and Endo, 1997; Silberstein et al.,
1998) and reduces ERAD efficiency for soluble ERAD substrates. Growth of the
Δscj1Δjem1 strain is unaffected at 26˚C but exhibits a slow growth phenotype at elevated
temperatures (Nishikawa & Endo, 1997). An ERdj3 construct was created that could be
expressed under the control of the GPD promoter in the multi-copy pGPD426 vector.
Wild type ERdj3 contains an ER signal sequence and thus is targeted to the ER, while the
CaaX-ERdj3 mutant no longer contains the ER targeting signal sequence and has a
CaaSQ farnesylation sequence at the C-terminus, targeting it to the cytosolic side of the
ER membrane. The farnesylation sequence is the same as that found in Ydj1 and is
necessary for Ydj1’s function at elevated temperatures (Caplan et al., 1992). Expression
of ERdj3 did not affect the growth of wild-type Scj1Jem1 yeast cells (Figure 3-2A).
However, ER expressed ERdj3 was unable to rescue the slow growth phenotype of the
∆Scj1∆Jem1 strain at elevated temperatures (Figure 3-2A). This was not due to poor
expression of mammalian ERdj3 in the yeast ER as determined by fluorescence staining
(data not shown). As a major function of DnaJ proteins is to stimulate the ATPase
activity of their Hsp70, we examined the ability of ERdj3 to stimulate the ATPase
activity of Kar2p. As expected, the basal ATPase activity of Kar2p was quite low but
could be stimulated ~4.3 fold by the J domain of Sec63, a yeast ER DnaJ (Corsi &
Schekman, 1997). However, ERdj3 only modestly enhanced the ATPase activity of
Kar2p (about 1.3 fold), suggesting that this might be the reason that ERdj3 could not
complement the ∆Scj1∆Jem1 strain. (Figure 3-2B)
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Figure 3-1.

Mammalian ER expressed Ydj1 interacts with both BiP and κLC

(A) Cos cells were co-transfected with cDNAs encoding BiP and the indicated HAtagged ERdj3 or Ydj1 constructs. Metabolically labeled, cross-linked cell lysates were
immunoprecipitated with anti-HA, anti-BiP or Protein A Sepharose alone. Isolated
proteins were separated by reducing SDS-PAGE. (B) Cos cells were co-transfected with
cDNAs encoding κLC and either ERdj3 or Ydj1 constructs. Samples were analyzed as
described in (A).
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Figure 3-2. ER expressed ERdj3 does not rescue the slow growth phenotype of the
scj1jem1 strain
(A) Ten-fold serial dilutions were performed on selective media of wild-type
(SCJ1JEM1) and mutant (scj1 jem1 ) yeast strains containing an empty vector (GDP),
a vector for the expression of an ER-targeted form (ERdj3), or a vector encoding a
cytosolically localized form (CaaX) of full-length ERdj3. Each protein was expressed
from a multi-copy vector containing the constitutive PGPD promoter. The plates were
incubated for 2 days at the indicated temperatures. (B) ERdj3 does not stimulate the
ATPase activity of Kar2p. The ATPase activity of Kar2p was measured either by itself
or in the presence of either ERdj3 or the J domain of Sec63. Reactions contained 1 mg of
Kar2p, 1:1 molar ratio of Kar2p: Sec63 J domain, or an eight-fold molar excess of the
ERdj3 protein. ATPase activity is expressed as nmoles of ATP hydrolyzed per milligram
of protein per minute (nmol ATP hydrolyzed/mg/min). Data represent the means of a
minimum of three independent experiments.
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3.3.3 Overexpression of cytosolically localized ERdj3 rescues the temperature-sensitive
defect of the hlj1Δ ydj1-151 strain
Since our previous data suggested that ERdj3 was structurally very similar to Ydj1,
we next determined if it could compensate for the loss of Ydj1. Ydj1p and Hlj1p (two
yeast cytosolic DnaJ proteins) interact with Ssa1p, the yeast cytosolic Hsp70 and are
functionally redundant (Youker et al., 2004). The hlj1Δ ydj1-151 mutant strain lacks
Hlj1p and expresses a conditional mutant form of Ydj1, Ydj1-151p. This mutant shows
reduced efficiency for ER-associated degradation (ERAD) and exhibits a slow growth
phenotype at elevated temperatures (Youker et al., 2004). Expression of CaaX-ERdj3 in
the cytosol of wild-type HLJ1 YDJ1 yeast cells did not affect their growth (Figure 3-3A).
However, when the hlj1Δ ydj1-151 strain expressing CaaX-ERdj3 was grown at elevated
temperatures, we found that the expression of CaaX-ERdj3 allowed growth at
temperatures up to 37˚C (Figure 3-3A). Recombinant ERdj3 was tested for its ability to
stimulate the ATPase activity of Ssa1 and found to do so at a level similar to Hlj1 (Figure
3-3B). These results demonstrated that CaaX-ERdj3 could act as a cochaperone of Ssa1p
and compensate for the loss the Ydj1, which allowed us to next examine the requirements
for substrate binding by expressing the various ERdj3 mutants.
3.3.4 Mutations in ERdj3 that affect substrate binding are unable to rescue the slow
growth phenotype of hlj1Δ ydj1-151 strain
The binding of ERdj3 to substrates was recently shown to be dependent on three
things: 1) the presence of domain II, 2) the pocket formed by hydrophobic amino acids in
domain I, and 3) dimerization, which occurs through the interactions in the C-terminal
region of which phenylalanine 326 is critical (Chapter 1). To determine whether the
ability to bind substrates is required for ERdj3 to compensate for the loss of Ydj1, seven
ERdj3 mutants were expressed in yeast. These included ones in which domain II was
either simply deleted (∆II) or replaced by a “GSGG” linker sequence (∆II-GSGG), two
mutants in which dimerization was inhibited (F326A and F326D), and finally, two single
amino acid substitutions in domain I (I134A and L208A) and one in which all four
hydrophobic residues affecting substrate binding were altered (IVLF-A). All mutations
were constructed on the CaaX-ERdj3 background. Expression of each of these mutants
in the HLJ1 YDJ1 strain did not affect cell growth (Figure 3-4A), however, none of them
were able to rescue the temperature-sensitive slow phenotype of the hlj1Δ ydj1-151 strain
(Figure 3-4B). Indeed, expression of most of the mutants actually enhanced the
temperature-sensitivity of this strain (Figure 3-4B). The fact that the CaaX-F326A/D
mutants were unable to rescue the slow growth phenotype, argues that dimerization of
CaaX-ERdj3 is required for its function in yeast. The failure of these mutants to
complement was not due to an inability to stimulate the ATPase activity of Ssa1, since all
mutants were able to stimulate ATP hydrolysis to levels that are comparable to both Hlj1
and wild-type ERdj3 (Figure 3-4C). Nor was it likely to be due to inadequate expression,
as at least two of the mutants, CAAX-∆II-GSGG and CAAX-F326D, were expressed at
similar levels as the wild-type CaaX-ERdj3 protein (Figure A-3). These results argue
that the cytosolically disposed ERdj3 requires its substrate binding activity to constitute a
functional pair with Ssa1 in yeast.
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Figure 3-3. Cytosolic expression of ERdj3 rescues the temperature-sensitive
growth phenotype of the hlj1∆ydj1-151 strain
(A) an empty vector (GDP), a vector containing an ER-targeted form (ERdj3), or a vector
engineered to produce a cytosolically localized form (CaaX) of full-length ERdj3 were
expressed in wild-type (HLJ1YDJ1) and mutant (hlj1∆ydj1-151) yeast strains as
described in Figure 3-2A. The plates were incubated for 2 days at the indicated
temperatures. (B) ERdj3 robustly stimulates Ssa1’s ATPase activity. The ATPase
activity of Ssa1 was measured either by itself or in the presence of ERdj3 or Hlj1 as
described in Figure 3-2B. The molar ratio of Ssa1 to the DnaJ proteins is 1:2.
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Figure 3-4. ERdj3 substrate binding mutants cannot rescue the temperature
sensitive growth phenotype of the hlj1∆ydj1-151 strain.
Cytosolically forms (CaaX) of wild type or mutant ERdj3 were expressed in wild type
(HLJ1YDJ1) (A) or mutant (hlj1∆ydj1-151) yeast strains (B). They were plated and
allowed to grow as described in Firgure 2. (C) All ERdj3 mutants stimulate Ssa1’s
ATPase activity. The ATPase activity of Ssa1 was measured either by itself or in the
presence of the indicated DnaJ proteins as described in Figure 3-2B. The molar ratio of
Ssa1 to DnaJ proteins is 1:2.
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3.4

Discussion

As cochaperones of Hsp70, DnaJ proteins allow Hsp70s to function by stimulating
their ATPase activity. The fact that a given Hsp70 in many organelles often has multiple
DnaJ cochaperones has led investigators to suggest that association with different DnaJ
proteins determines the functional diversity of Hsp70 proteins. We demonstrated that
ER-expressed Ydj1 associated with BiP and specific ERdj3 substrates in mammalian
cells, which led to a further investigation of the principles regulating the formation of
functional DnaJ/Hsp70 pairs. We found that ERdj3 cannot compensate for the loss of
yeast Scj1, which is an ER localized Dna J protein. However, ERdj3 could compensate
for the loss of Ydj1 when it was expressed in the yeast cytosol. Since ATPase activity is
imperative for the function of Hsp70, the failure of ERdj3 to efficiently stimulate the
ATPase activity of Kar2p, a Hsp70 in yeast ER, may explain the inability of ERdj3 to
compensate Scj1. It was also demonstrated that CaaX-ERdj3 can functionally interact
with Ssa1 and compensate the loss of Ydj1. These results suggest that both Ydj1 and
ERdj3 can interact with an alternative Hsp70 and must be able to bind to at least some
substrates in the other cell type, even though they originate from different organelles in
different organisms. In some cases the ability to stimulate Hsp70 ATPase activity is
sufficient for many cellular processes (Sahi & Craig, 2007). Our data suggests this is not
sufficient in the case of the ERdj3/Ssa1 pair, as all of the substrate binding mutants were
able to stimulate the Ssa1’s ATPase activity in vitro but were unable to compensate for
the loss of Ydj1 in vivo. This is in contrast to a recent study where growth defects caused
by the loss of Ydj1 could be attenuated by the expression of various cytosolic DnaJ
proteins or even only their J domains (Sahi & Craig, 2007). However, unlike present
study, their study was done in the background only deleting Ydj1. It is likely that other
cytosolic DnaJ proteins (Hlj1) can functionally overlap with Ydj1 in vivo.
In the present study, we found that the ΔII mutant retains its ability to stimulate
Ssa1 but cannot compensate for the loss of Ydj1, suggesting that deletion of domain II
does not grossly affect ERdj3’s overall structure and agreeing with previous findings that
domain II has an essential role in both Ydj1 and DnaJ function (Szabo et al., 1996; Lu et
al., 1998). It was suggested that the cysteines of domain II are important for maintaining
the ability of these DnaJ proteins to bind substrate or to cooperate with Hsp70 in
substrate folding. In contrast to other type I DnaJ proteins whose cysteine residues form
zinc binding sites, the four cysteines that are present in ERdj3 form intra-chain disulfide
bonds in domain II. In a recent study using mutational analyses, these cysteines were
argued to be essential for the in vitro binding of ERdj3 to denatured thyroglobulin and
immunoglobulin (Marcus et al., 2007). Because the yeast cytosol has a more reducing
environment than that of the mammalian ER, one might expect that the critical disulfide
bonds would not form. The fact that ERdj3 was able to compensate for loss of Ydj1
argues that either the disulfide bonds do form even in the reducing environment or that
they are not necessary for function in this context. In support of the first possibility, it
has been reported that ER proteins which fold quite stably can form disulfide bonds even
in the presence of DTT (Hellman et al., 1999). In addition, we previously demonstrated
that reduced ERdj3 can interact not only with BiP but also with substrate in vivo when
cells are treated with DTT (Shen et al., 2005). Thus, the requirement for these cysteines
in the mutational study might reflect either the presence of altered amino acids in these
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positions or a more stringent requirement for the disulfide bonds in these particular in
vitro assays. It is also conceivable that the binding of Zn2+ to the cysteines in domain II
of ERdj3 when it is expressed in the yeast cytosol is able to stabilize this domain and that
conversely the formation of disulfide bonds in domain II of Ydj1 when it is in the
mammalian ER serves a similar purpose.
Previous crystallographic studies of the peptide binding fragment of Ydj1 and Sis1
(Sha et al., 2000; Li et al., 2003; Li & Sha, 2005) and the mutagenesis study of ERdj3’s
substrate binding domain (Chapter 1) suggest that type I and type II DnaJ proteins are
likely to possess a very similar substrate binding structure. Since the substrate binding
domains of Ydj1 and Sis1 are required for robust growth of yeast cells (Johnson et al.,
2001), a number of genetic reconstitution studies have been performed (Sahi & Craig,
2007). Sis1, which is a type II family member, is able to complement loss of Ydj1 (Sahi
& Craig, 2007), as was ERdj3 in the present study. However, loss of Sis1 is not
complemented by Ydj1 (Luke et al., 1991). Based on our studies showing that substrate
binding is important for complementation, it is reasonable to suggest that Sis1 is able to
bind Ydj1 substrates that are critical for growth, whereas Ydj1 may not be able to interact
with an essential Sis1 substrate. The fact that the actual sequence of domain I of these
DnaJ proteins is not highly conserved is consistent with this possibility.
These studies demonstrate that both substrate binding and the ability to stimulate
Hsp70 ATPase activity are crucial in the formation of functional DnaJ/Hsp70 pairs. They
further suggest that DnaJs exhibit more promiscuity in binding to various substrates than
in interaction with Hsp70s. This discovery has implications for models in which different
DnaJ proteins allow Hsp70s to contribute to diverse and sometimes opposing cellular
functions.

41

CHAPTER 4. REGULATED RELEASE OF ERDJ3 FROM UNFOLDED
PROTEINS BY BIP 1
4.1

Introduction

The Hsp70 family of molecular chaperones is a highly conserved, widely
expressed, and well-studied group of proteins. These chaperones are found in all
organisms where they play a role in every cellular organelle and are essential to nearly all
cellular processes. The binding of Hsp70 proteins to non-native structures on a vast array
of substrate proteins can serve to stabilize folding intermediates, prevent their
aggregation, and aid in protein folding and assembly. This is achieved via direct
interaction of the C-terminal substrate binding domain (SBD) of Hsp70 proteins with
exposed hydrophobic residues on substrate proteins (Erbse et al., 2004). Peptide binding
studies have been performed on BiP (Flynn et al., 1991; Blond-Elguindi et al., 1993), the
Hsp70 cognate of the mammalian endoplasmic reticulum (ER), on Hsc 70 (Gragerov &
Gottesman, 1994), a cytosolic mammalian Hsp70, and on DnaK (Rudiger et al., 1997),
the E. coli family member. Although differences exist, overall the studies suggest that
Hsp70 proteins prefer peptides of 5 – 10 amino acids, which are predominantly
hydrophobic in nature, and which have been estimated to occur approximately every 1620 amino acids in the average protein (Flynn et al., 1991). In the case of BiP, the
preferred peptides contain hydrophobic amino acids in alternating positions (BlondElguindi et al., 1993). This configuration is most compatible with a preference for
extended chains in which the hydrophobic amino acids would be oriented in a single
direction to engage the peptide binding pocket of the Hsp70 protein, a possibility that is
supported by NMR (Landry et al., 1992) and crystallographic (Zhu et al., 1996) studies.
The binding and release of substrates to the SBD of Hsp70 proteins is tightly
regulated by the highly conserved N-terminal nucleotide binding domain (NBD) (Liberek
et al., 1991b), which can bind either ATP or ADP. When ATP occupies the cleft of the
NBD, the SBD is in an open configuration, which has both a high on and high off rate for
unfolded proteins. The hydrolysis of ATP to ADP results in a closure of the lid on the
SBD, which stabilizes the interaction with bound proteins. Discharge of the unfolded
protein occurs when ADP is released and exchanged for ATP. This reopens the lid on the
SBD, which allows the bound substrate to be released and provides an opportunity for it
to fold. A number of recent studies shed light on the interaction between the two
domains, which controls the activity of this group of chaperones (Jiang et al., 2005;
Vogel et al., 2006a; Vogel et al., 2006b; Liu & Hendrickson, 2007; Awad et al., 2008).
The Hsp70 ATPase cycle, which is essential to the chaperoning process, is
controlled by a number of co-factors that regulate either ATP hydrolysis or nucleotide
exchange. DnaJ was originally identified along with DnaK (Hsp70) in a genetic screen in
E. coli for genes that are required for DNA replication (Saito & Uchida, 1977; Yochem et
al., 1978). Later it was shown that DnaK and DnaJ are in the same genetic pathway and
1

Chapter 4 modified from an article accepted for publication by EMBO Journal (Jin Y, Awad W, Petrova
K, and Hendershot LM, Regulated release of ERdj3 from unfolded proteins by BiP. EMBO J. In press.).

42

that DnaJ stimulates the ATPase activity of DnaK, thereby stabilizing the binding of
DnaK to substrates (Liberek et al., 1991a). As is the case with Hsp70s, DnaJ proteins are
present in all organisms and all organelles, and the number of DnaJ proteins in an
organism often exceeds the number of Hsp70 proteins present (Caplan et al., 1993;
Cheetham & Caplan, 1998). DnaJ proteins all possess a highly conserved ~70 amino
acid “J” domain, which contains an invariant tripeptide sequence, His-Pro-Asp, that is
required to interact with the ATP-bound form Hsp70 proteins (Mayer et al., 1999). Like
Hsp70 proteins, at least some DnaJ proteins can bind directly to unfolded substrates
(Cheetham et al., 1998; Fan et al., 2003). Peptide binding studies for E. coli DnaJ
revealed significant overlap with the peptides that bound DnaK (Rudiger et al., 2001),
arguing that DnaJ was likely to also bind to extended hydrophobic residues on unfolded
proteins. This possibility was supported by crystallographic data obtained for a peptide
bound to the yeast cytosolic DnaJ protein, Ydj1 (Li et al., 2003). The fact that DnaJs
specifically interact with the ATP bound form of Hsp70s led to a model (Walter &
Blobel, 1983; Mayer et al., 1999) where DnaJ proteins would bind first to unfolded
proteins, recruit the ATP-bound or “open” form of Hsp70 to the substrate, and then
stimulate its ATPase activity to “close” it onto the substrate more stably. This model was
supported by data showing that a cytosolic DnaJ protein bound to nascent chains
extruding from the ribosome before the Hsp70 protein did (Hendrick et al., 1993), and by
in vitro binding studies with DnaK, DnaJ, and denatured luciferase (Szabo et al., 1994).
However, these studies did not reveal how DnaJ proteins were released from the
substrate. Unlike Hsp70, DnaJ proteins do not bind to nucleotide and have not been
demonstrated to exist in different conformational states.
The mammalian ER possesses at least six DnaJ family members (Brightman et al.,
1995; Meyer et al., 2000; Tyedmers et al., 2000; Yu et al., 2000; Shen et al., 2002;
Cunnea et al., 2003; Rutkowski et al., 2007; Petrova et al., 2008). One of these, ERdj3,
was shown previously by our group to bind to a number of unfolded proteins in the ER
that were BiP substrates (Shen and Hendershot, 2005). When the binding of wild-type
and mutant (HPD→QPD) ERdj3 to several different substrates was compared, we
consistently found that mutant ERdj3 bound quantitatively better and longer than wildtype ERdj3 (Shen et al., 2005). The present study was undertaken to better understand
the requirements for releasing DnaJ proteins from substrates. Using a series of ERdj3
and BiP mutants, we found that release of ERdj3 was not simply due to a competition or
exchange with BiP, but that a functional interaction between ERdj3 and BiP was
required. We hypothesize that in addition to the ERdj3-induced conformational change
that occurs in BiP, which stabilizes BiP’s binding to the unfolded protein, that there is a
reciprocal change in the conformation of ERdj3 that triggers its release from substrate.
4.2

Materials and Methods

4.2.1 Cell culture, transfection, and immunoprecipitation
COS-1 monkey kidney fibroblast cells were maintained in DMEM supplemented
with 10% fetal bovine serum, 2mM L-glutamine, and 1% Fungisone in 3% CO2. Cells
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were transfected with the indicated vectors using the Fugene 6 transfection reagent
(Roche Diagnostics), and after forty-eight hours post-transfection, cells were labeled with
35
S Translabel (Amersham Biosciences) for 3h. Cells were treated with 150 μg/ml 3,3’dithio-bis (propionic acid N-hydroxysuccinimide ester) (DSP), a membrane permeable
cross-linking reagent (Sigma-Aldrich) for 1h on ice. Cell lysates were prepared using an
NP40 lysing buffer and immunoprecipitated with indicated antisera followed by binding
to Protein A Sepharose beads. The immunoprecipitated complexes were analyzed by
SDS-PAGE under reducing conditions, and the signal was detected using Amplify
(Amersham Bioscience) for radiographic visualization.
4.2.2 In vitro translation and heavy chain binding assay
Ag8.8 murine plasmacytoma cells were maintained in RPMI 1640 supplemented
with 10% fetal bovine serum, 2mM L-glutamine, and 1% Fungizone in 5% CO2. Cells
were metabolically labeled for 16h with 35S Translabel (Amersham Biosciences) and
treated with or without DSP prior to lysing. Cell lysates were prepared and Ig heavy
chains were isolated by binding to Protein A as described previously (Wei et al., 1995).
To release BiP from heavy chains, non-cross-linked samples were supplemented with 1
mM MgCl2, 25 mM KCl, and 1 mM ATP. These samples are the source of free HC used
in the in vitro binding assays, except that the beads were washed an additional three times
in PBS to reduce detergent in the samples, which interferes with the ability of ERdj3 to
remain associated with unfolded substrates (Shen et al., 2005).
The cDNAs encoding wild type and mutant (H35Q) ERdj3 were transcribed from
the T7 promoter of 3HADSL-ERdj3 (Stratagene) and translated using 35S methionine
(Amersham Biosciences) and the TNT coupled rabbit reticulocyte lysate (Promega).
Equivalent counts for the two protein products were loaded directly on reducing SDSpolyacrylamide gels or incubated with either uncoupled Protein A Sepharose beads
(washed three times in PBS), or with the Protein A Sepharose beads to which free γHC
were bound. After incubating for 1h on ice, the beads were washed three times with PBS
and bound proteins were subjected to reducing SDS-PAGE.
4.2.3 IP western
Firefly luciferase (Promega) was left untreated (N) or heat denatured (D) at 42°C
for 1h. In both cases, 0.5 μg of protein was incubated with recombinant wild type ERdj3
protein (2.0μg) in PBS and immunoprecipitated with either anti-ERdj3 polyclonal
antiserum followed by protein A Sepharose beads or with protein A Sepharose beads
alone. Bound proteins were subjected to reducing SDS-PAGE and then transferred to a
PVDF membrane (BIO-RAD), which was blotted with an anti-luciferase antiserum
(1:1000) (Promega). Donkey anti-goat Ig conjugated to HRP (1:5000) was used as a
secondary antibody and the signal was detected by chemiluminescence (ECL).
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4.2.4 Protein purification
Expression of His-tagged wild-type and mutants ERdj3 was induced in E. coli M15
cells with 0.1 mM isopropyl β-D-thiogalactoside (Sigma) followed by growth for 18 h at
18°C. The recombinant proteins were purified on Ni2+-agarose columns under nondenaturing conditions (Qiagen QIAexpress system), dialyzed in 25mM sodium phosphate
buffer (pH 7.0), containing 150mM NaCl, 0.02% Triton X-100, 50% glycerol, and a
protease inhibitor cocktail (Roche), and stored at -20°C. His-tagged wild-type and
mutant BiP proteins were induced with 1 mM IPTG for 2h at 37°C, purified on Ni2+agarose columns, dialyzed and stored in 20mM HEPES buffer (pH 7.2) with 50mM KCl,
5mM MgCl2, 0.01% NP-40, 50% glycerol, and a protease inhibitor cocktail.
4.2.5 Measurement of complex formation between ERdj3 proteins and denatured
luciferase
Firefly luciferase was denatured in buffer containing 7M Urea, 25mM HEPES (pH
7.5), 50mM KCl, 5mM EDTA, 5mM MgCl2 and 5mM dithiothreitol at room temperature
for 40 min and then diluted into PBS containing 0.05% BSA (final concentration 0.5
µg/ml). 100 µl of this solution was added into each well of a 96-well microtiter plate
purchased from Theromo (Immulon 2HB Flat Bottom Microtiter Plate) and allowed to
bind overnight at 4ºC. Wells were washed with PBS and blocked with 200 μl PBS
containing 1% BSA for 1h at room temperature. The indicated concentrations of wild
type or mutant ERdj3 in 100 μl of PBS with 0.05% BSA was added to the wells and
incubated for 1h at room temperature, followed by washing with PBS to remove
unbounded ERdj3. The amount of ERdj3 that remained bound to denatured luciferase
was detected with a polyclonal anti-ERdj3 antiserum (Shen et al., 2005) followed by
donkey anti-rabbit Ig conjugated to alkaline phosphatase (Promega). 4-Nitrophenyl
phosphate disodium salt hexahydrate (Sigma) was added, and after stopping the reaction
with 0.75 M NaCl, the plates were read on a spectrophotometer at wavelength 405nM.
Negative controls were set up for each plate in wells that did not contain either denatured
luciferase, ERdj3, or each of the antibodies, but which included all the other steps of the
reaction.
4.2.6 Release of ERdj3 from luciferase
To detect the amount of BiP binding to denatured luciferase, recombinant hamster
BiP was added to wells coated with denatured luciferase instead of ERdj3, and incubated
as above, except that a rabbit polyclonal anti-rodent BiP antiserum was used to detect BiP
binding. To test the ability of wild-type and mutant BiP to release ERdj3 from luciferase,
ERdj3 was first bound to luciferase as above. After washing away unbound ERdj3, the
indicated amounts of recombinant BiP proteins were added to the wells in PBS
containing 1 mM MgCl2, 25 mM KCl and either 1 mM ATP or no nucleotide. The plates
were incubated for 1 hr at room temperature, and the amount of ERdj3 or BiP associated
with the denatured luciferase was determined as above.
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4.2.7 ATPase assay
ATPase assays were performed as described previously (Chevalier et al., 1998).
Briefly, 1µM of the various recombinant BiP proteins was incubated alone or with 0.5
µM of the indicated full length ERdj3 proteins at 37°C for 20 min in ATPase buffer
containing [-32P]ATP (PerkinElmer). After chromatography, the radioactive ATP and
free phosphate signals were quantified by phosphoimager analysis (Molecular Dynamics,
Sunnyvale, CA) using Image Quant software. The free phosphate signal was expressed
as a percent of the total phosphate signal. Data were deduced from three independent
experiments, and the error bars represent standard deviations (S.D.).
4.3

Results

4.3.1 Comparison of the effects of J domain mutations on ERdj3’s ability to associate
with substrate both in vivo and in vitro
It has been shown that the J domains of DnaJ proteins are important for interactions
with their Hsp70 partners, where the signature HPD motif in the J domain plays an
indispensable role. We previously demonstrated that a QPD mutation in ERdj3
abrogated its ability to interact with its ER Hsp70 partner-BiP both physically and
functionally (Shen et al., 2005). To determine whether the interaction with BiP was
crucial for ERdj3’s ability to bind to unfolded substrates, we examined the ability of
wild-type and mutant ERdj3 to bind to immunoglobin heavy chain (γHC) both in vivo
and in vitro. First, we co-expressed γHC along with HA-tagged versions of either wildtype ERdj3 or two different J domain mutants (both QPD and ∆ J) in COS cell. Coimmunoprecipitation experiments were performed on DSP-cross-linked cell lysates. We
found that J domain mutations did not negatively affect the ability of the mutant ERdj3
proteins to bind to γHC in vivo (Figure 4-1A). In fact, in both cases there was actually
more binding of the QPD and ΔJ mutants to the γHC as compared to the binding of wildtype ERdj3. Wild type and mutant ERdj3 proteins were also expressed in COS cells
alone. Protein A Sepharose beads did not precipitate any of three proteins (Figure B-1)
demonstrating that the binding observed in Figure 4-1A is dependent on the coexpression of γHC. These data suggested two things; first, since these mutants are unable
to interact with BiP, ERdj3 might bind directly to unfolded substrates, and second these
ERdj3 mutants might have a higher affinity for substrate or some component of the ER
chaperone complex (Meunier et al., 2002). To directly test the first possibility, we
developed an in vitro assay to examine the binding of ERdj3 to γHC in the absence of
other resident ER chaperones and folding enzymes. It was based on our previous
demonstration that BiP can be released from isolated HC in vitro with ATP leaving the
HC in a conformation that allows them to reassociate with exogenously added BiP (Wei
et al., 1995). As shown in Figure 4-1B (lane 1), ERdj3 can be isolated with γHC only
when cells are pretreated with a membrane permeable crosslinker, DSP, whereas BiP’s
association with γHC is detectable even without crosslinking (Figure 4-1B, lane3).
However, addition of ATP releases BiP from the γHC (Figure 4-1B, lane2). These free
HC were used for binding to in vitro translated ERdj3 proteins (Figure 4-1C). We found
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Figure 4-1.

ERdj3 binds to HC directly

(A) Cos cells were co-transfected with cDNAs encoding  HC and the indicated HAtagged ERdj3 constructs. Metabolically labeled, cross-linked cell lysates were
immunoprecipitated with anti-HA or Protein A Sepharose alone. Isolated proteins were
separated by reducing SDS-PAGE. (B) Ag8.8 cells were metabolically labeled for 16h
with 35S methionine and cysteine and incubated with (lane 1) or without (lanes 2 and 3)
DSP. Cell lysates were prepared with (lane 2) or without (lanes 1 and 3) ATP and
immunoprecipitated with Protein A Sepharose. (C) Wild-type (WT) and QPD mutant
(Mut) ERdj3 were in vitro translated and run directly (lanes 6 and 7) or incubated with
the free  HC immobilized on protein A Sepharose beads prepared as in lane 2 in Figure
4-1B (lanes 2 and 3) or with protein A beads alone (lanes 4 and 5).
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that unlike the in vivo binding assays, the QPD mutant bound to γHC at similar levels as
observed for wild-type ERdj3 (Figure 4-1C, lanes 4 and 5). These data revealed that
ERdj3 associates directly with substrates and also argues that the enhanced binding of
ERdj3 mutants to γHC in vivo is unlikely to be due to their having a higher affinity for
substrate. Instead, it suggested that something else in the cell might be contributing to
the difference between wild-type and mutant ERdj3’s association with substrate. Based
on our previous data showing that mutant ERdj3 remains bound to unfolded Ig light
chains much longer than wild-type ERdj3 (Shen et al., 2005), we hypothesized that the J
domain mutations might be affecting release of the ER DnaJ proteins from substrates and
that release might be dependent on a functional interaction with BiP.
4.3.2 Development of an in vitro system to detect binding and release of ERdj3 from
substrates
Because the isolation of free HC was somewhat cumbersome, we wished to
develop a simpler in vitro binding assay. We chose denatured firefly luciferase (D-Luc),
because it has been widely used as an in vitro substrate for other DnaJ family members,
including E. coli DnaJ and two yeast cytosolic DnaJ family members Sis1 and Ydj1
(Szabo et al., 1994; Schumacher et al., 1996; Lu & Cyr, 1998a; Lu & Cyr, 1998b). To
determine if denatured luciferase could serve as an ERdj3 substrate in vitro, we examined
the ability of wild-type ERdj3 to bind to either native or heat denatured luciferase in
solution. For these experiments we denatured luciferase with heat instead of urea,
because we did not want to interfere with the protein: protein interactions required for
association and for immunoprecipitation. ERdj3 was allowed to interact with native or
denatured luciferase and the samples were immunoprecipitated with either a polyclonal
anti-ERdj3 antiserum or Protein A Sepharose beads.The association of luciferase was
determined by immunoblotting with an anti-luciferase antibody. We found that indeed
the binding of ERdj3 to denatured luciferase (D) was readily detectable, whereas its
binding to native luciferase (N) was below the level of detection (Figure 4-2A). This
distinction in binding is in keeping with ERdj3 acting as a chaperone and demonstrated
that denatured luciferase could be used as an in vitro substrate for ERdj3.
Next a modified ELISA was developed, which would allow us to readily examine
the ability of ERdj3 to bind to luciferase under multiple conditions. For this assay, the
luciferase was chemically denatured, as has been done in a number of other studies
(Szabo et al., 1994; Lu et al., 1998a). First, we tested the binding of wild-type ERdj3 and
the QPD mutant to chemically denatured luciferase which was bound to 96-well plates.
Similar to the in vitro binding of these proteins to γHC, we found that both wild-type
ERdj3 and the QPD mutant associated with chemically denatured luciferase equally
(Figure 4-2B). Thus, mutation of HPD sequence to QPD did not affect the binding of
ERdj3 to chemically denatured luciferase.
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Figure 4-2.

WT and QPD ERdj3 bind to denatured luciferase similarly in vitro

(A)Temperature denatured (D) or native (N) luciferase (Luc) was incubated with
recombinant wild type ERdj3 protein and then immunoprecipitated with either antiERdj3 polyclonal antiserum or with protein A Sepharose beads alone. Reaction cocktails
were subjected to reducing SDS-PAGE and then transfer to a PVDF membrane. The
membrane was blotted with goat anti-luciferase antiserum followed by donkey anti-goat
Ig conjugated to HRP. The signal was detected by chemilluminesence. (B) Chemically
denatured luciferase (grey bars) or binding buffer alone (hatched bars) was used to coat
96-well plates. After washing and blocking with 1% BSA, recombinant wild-type or the
QPD mutant ERdj3 proteins (0.5 µM) were added to the wells and incubated for 1 hr at
RT. After washing, bound ERdj3 was detected with a polyclonal anti-ERdj3 antiserum,
followed by donkey anti-rabbit Ig conjugated to alkaline phosphatase. The DNTP
substrate was added and after developing, the plates were read on a spectrophotometer
and the signal was expressed in OD units. A luciferase coated well that did not receive
ERdj3 protein was treated similarly and serves as a negative control for the antibody
(dark grey). All samples were run in triplicate and error bars are indicated.
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4.3.3 ATP does not affect the binding of wild type ERdj3 or the QPD and HPN
mutants to substrate in vitro
Before testing our hypothesis that ERdj3 release from substrates occurs in response
to a functional interaction with BiP, it was necessary to set up an assay to saturate the
binding of ERdj3 to luciferase and to ensure that incubation with ATP did not affect this
binding. Increasing concentrations of wild-type (Figure 4-3A), QPD (Figure 4-3B), or
HPN (Figure 4-3C) recombinant ERdj3 proteins were added to luciferase coated wells in
the absence (Figure 4-3 solid bar) or presence (Figure 4-3 stippled bar) of ATP. We
found that all three proteins reached saturation binding at concentrations of~500nM and
that the inclusion of ATP in the binding buffer did not affect ERdj3’s ability to bind to
substrate. Thus, in the following experiments 500 nM ERdj3 was used.
4.3.4 BiP promoted the release of wild-type ERdj3 from chemically denatured
luciferase in the presence of ATP
If a functional interaction between BiP and ERdj3 is critical for releasing ERdj3
from substrates, the amount of ERdj3 that is associated with substrate is expected to
decrease in the presence of BiP in an ATP-dependent manner. To examine this
possibility, increasing amounts of BiP were added to wells containing ERdj3 bound to
denatured luciferase in the absence and presence of ATP (Figure 4-4A). We found that
the addition of increasing amounts of BiP in the absence of ATP did not affect ERdj3’s
association with denatured luciferase (Figure 4-4A, solid bar), although there was a
detectable increase in the binding of BiP to the substrate (Figure 4-4B, solid bar). This
demonstrates that release of ERdj3 does not occur via a simple competition between
these two chaperones for substrate and further suggests that BiP and ERdj3 binding sites
are not completely overlapping. However, when ATP was included with BiP, we found
that the ability of BiP to release ERdj3 was dependent not only on the concentration of
BiP, but also required ATP (Figure 4-4A stippled bar). The binding of BiP to denatured
luciferase did not increase (Figure 4-4B stippled) when ERdj3 was released (Figure 4-4A
stippled bar), again suggesting that ERdj3 release does not occur due to a simple
competition with BiP. To examine this from the other direction, we first bound either
wild-type BiP or a BiP mutant that cannot interact with ER DnaJ proteins (R197H)
(Awad et al., 2008) to denatured luciferase and measured the ability of ERdj3 to release
them. We found that the addition of ERdj3 did not induce a reduction in the binding of
either wild-type or mutant BiP to luciferase coated well (Figure 4-4C solid and stippled
bars), even though we could readily measure the binding of ERdj3 to luciferase (Figure
4-4C checkered bars). This further argues that the release of ERdj3 does not occur due to
a simple competition between BiP and ERdj3 for binding sites on the substrate.
4.3.5 BiP mutants that do not interact with ERdj3 failed to promote the release of
ERdj3 from substrate
The requirement of ATP for BiP to release ERdj3 from the substrate suggested that
a functional interaction between BiP and ERdj3 might be necessary. To test this
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Figure 4-3. WT and mutant (QPD and HPN) ERdj3 bind to D-Luc similarly and
ATP does not affect their binding
Chemically denatured luciferase was used to coat the wells and the indicated amounts of
WT (A) QPD (B) or HPN (C) ERdj3 were added to the wells with (stippled bar) or
without (solid bar) ATP. The plates were developed with anti-ERdj3 as described in
Figure 4-2. The arrow indicates the concentration of ERdj3 that was used in the
following experiments.
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Figure 4-4.

BiP releases ERdj3 from D-Luc in an ATP-dependent manner

(A) Chemically denatured luciferase was added to the wells followed by ERdj3 binding
as described previously. After washing, the indicated amounts WT BiP were added to the
ERdj3:luciferase complexes with (stippled bar) or without (solid bar) ATP and incubated
for an additional 1hr at room temperature. After washing, the amount of ERdj3 that
remained bound to luciferase was detected with an anti-ERdj3 antiserum. (B) On a
parallel plate the amount of BiP that was associated with luciferase was determined by
incubating with an anti-BiP antiserum. (C) Either wild-type or mutant (R197H) BiP was
allowed to bind to luciferase. After washing, ERdj3 was added to half the wells and the
amount of BiP that was bound without ERdj3 (solid bars) or with ERdj3 (stippled bars)
was measured with an anti-BiP antiserum. In a parallel set of wells, ERdj3 binding was
measured with an anti-ERdj3 antibody (checkered bars).
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possibility, we examined the ability of a number of different BiP mutants to release
ERdj3 from luciferase. A highly conserved arginine on the ATPase domain of Hsp70
proteins (R197 in BiP) has been shown to be essential for interaction with the HPD motif
on DnaJ proteins (Gassler et al., 1998; Suh et al., 1998; Alder et al., 2005). We recently
made three substitutions at this site (R197H, R197A, and R197E), all of which have
ATPase activity equal to or greater than wild-type BiP, but none of them can bind or be
further stimulated by J proteins (Awad et al., 2008). Two other BiP mutants were also
tested; a G227D mutant that cannot bind to ATP and a T37G mutant that cannot undergo
the ATP-induced conformational change that is required for its chaperoning activity (Wei
et al., 1995). Recombinant proteins corresponding to each of these mutants were made
and tested both for their ability to bind to luciferase and to release wild-type ERdj3. We
found that all five BiP mutants were able to bind equivalently to luciferase when tested at
a concentration of 50 µM (Figure 4-5A), whereas only very low levels of background
binding to the wells were observed for all of these proteins when luciferase was not
present (Figure B-2). Although all of the mutants bound to luciferase both alone and in
the presence of ERdj3 (Figure 4-5C), none of them was able to release ERdj3 from this
substrate even in the presence of ATP (Figure 4-5B).
4.3.6 Wild type BiP does not release two ERdj3 mutants, QPD and HPN, from
luciferase
To further explore the possibility that a functional interaction between ERdj3 and
BiP was required for ERdj3 release, we produced two ERdj3 proteins in which the HPD
motif had been mutated and therefore should not interact functionally with wild-type BiP
based on previously defined DnaJ mutants (Wall et al., 1994). The first of these,
HPD→QPD, disrupts binding to BiP and stimulation of its ATPase activity without
interfering with the ability of this mutant to bind to substrates (Shen et al., 2005). The
second mutant HPD→HPN corresponds to a DnaJ mutant that was defective in
interacting with wild-type DnaK (Suh et al., 1998). We first tested the ability of these
two mutants to bind to BiP in vivo and to stimulate its ATPase activity in vitro. Wildtype and mutant ERdj3 proteins were co-expressed in COS cells with BiP. Forty-eight hr
post-transfection metabolically labeled cells were incubated with DSP to cross-link
proteins and cell lysates were immunoprecipitated with either anti-BiP or anti-ERdj3
polyclonal antiserum (Figure 4-6A). We found that both mutations interfered with the
ability of ERdj3 to bind to BiP, which is in keeping with data from a number of other
DnaJ family members (Tsai & Douglas, 1996; Kelley & Georgopoulos, 1997; WittungStafshede et al., 2003). Recombinant full-length proteins corresponding to these mutants
were produced, and their ability to stimulate the ATPase activity of BiP was compared to
that of wild-type ERdj3. We found that wild-type ERdj3 stimulated BiP’s ATPase
activity about 2-fold, which is in keeping with previous data obtained with only the J
domain and glycine/phenylalanine regions of ERdj3 (Shen et al., 2005), whereas the
HPN and QPD mutants were unable to appreciably increase the hydrolysis of ATP
(Figure 4-6B).
We next performed an experiment similar to those described in Figures 4-4 and
4-5, except that this time we were asking if wild-type BiP was only capable of releasing
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Figure 4-5.

Only WT BiP releases ERdj3 from D-Luc

(A) Chemically denatured luciferase was added to the wells, which were then incubated
with wild-type or mutant BiP. The binding of BiP to D-Luc was performed in the
absence of ERdj3 and detected with anti-BiP serum. (B and C) Denatured luciferase was
added to wells and wild-type ERdj3 was allowed to bind as described. After washing,
either wild-type or mutant BiP was added with (stippled bars) or without (solid bars) ATP.
The amount of ERdj3 remaining was detected with an anti-ERdj3 antiserum (B) and the
binding of BiP was detected with an anti-BiP antiserum (C) and expressed in O.D. units.
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Figure 4-6.

Wild-type BiP can only release wild-type ERdj3 from D-Luc

(A) Cos cells were co-transfected with wild-type BiP and the indicated ERdj3 vectors.
DSP-cross-linked cell lysates were immunoprecipitated with anti-BiP or anti-ERdj3 and
analyzed by reducing SDS-PAGE. (B) ATPase assays were performed on wild-type BiP
alone or with a 4-fold molar excess of wild-type, HPN, or QPD ERdj3. ATP hydrolysis
was measured by quantitating ADP and expressing it as a percent of total nucleotide. (C)
An experiment similar to that described in the previous figure was performed, except that
either wild-type or mutant ERdj3 was bound to luciferase first. After washing, wild-type
BiP was added with (stippled bars) or without (solid bars) ATP. The amount of ERdj3
that remained bound was detected with an anti-ERdj3 antiserum and expressed in O.D.
units.

55

wild-type ERdj3 or if it was also able to release the two ERdj3 mutants that did not
functionally interact with BiP. If BiP released the ERdj3 mutants, it would argue that a
functional BiP/ATP/substrate interaction was required but that there was no need for a
functional BiP/ERdj3 interaction. We found that only wild ERdj3 was released by wild
type BiP in the presence of ATP, whereas both the QPD and HPN mutants remained
bound to the substrate even in the presence of ATP (Figure 4-6C). The combination of
this experiment and the previous one (Figure 4-5A) demonstrate that both a
BiP/ATP/substrate interaction and a functional BiP/ERdj3 interaction are required to
release ERdj3 from substrate.
In a search for allele specific suppressors of DnaJ HPN and QPD mutants, no
suppressors were found for the QPD mutant, but three different DnaK mutants were
identified that restored growth at temperatures that were non-permissive for the HPN
mutant (Suh et al., 1998). Of these, the DnaK R167H mutant (analogous to our R197H
mutant) bound better than wild-type DnaK to the DnaJ HPN mutant. Thus, we wished to
determine if our HPN ERdj3 mutant and our R197H BiP mutant would constitute a
functional pair that could rescue the inability of HPN ERdj3 to be released from
substrate. To determine this, we first measured the ability of both the QPD and HPN
mutants to bind to and stimulate the ATPase activity of R197H BiP, which cannot be
stimulated with wild-type ERdj3 (Awad et al., 2008). Wild-type and mutant ERdj3
proteins were co-expressed in COS cells with R197H BiP as described above. We found
that the HPN mutant was as defective in binding to R197H BiP mutant as either wildtype ERdj3 or the QPD mutant (Figure 4-7A). Thus, unfortunately the HPN ERdj3
mutant did not appear to re-establish a functional pair with the R197H BiP mutant by this
criterion. We also examined the ability of the various ERdj3 proteins to stimulate the
ATPase activity of R197H BiP, and found that only the HPN mutant showed a very
modest ability to stimulate the ATPase activity of R197H BiP (Figure 4-7B). However,
this weak stimulation is not comparable to the stimulation of WT ERdj3/ BiP pair. This
result is consistent with our in vivo binding data showing that HPN ERdj3 did not bind
detectably to R197H BiP, and suggested that the HPN ERdj3/R197H BiP pair did not
reform a functional pair as observed for the corresponding mutants in DnaJ and DnaK.
However, since two of the DnaK allele-specific suppressors of the HPN DnaJ
mutant did not bind better to HPN DnaJ than wild-type DnaK (Suh et al., 1998), we
proceeded to determine if our R197H BiP mutant could release the HPN ERdj3 mutant
from denatured luciferase. We found that R197H BiP was unable to release either the
wild type or the QPD ERdj3 mutant (Figure 4-7C), which is in keeping with the fact that
no allele specific suppressors were found for the DnaJ QPD mutant (Suh et al., 1998).
However, when we examined the interaction between the R197H BiP mutant and the
HPN ERdj3 mutant we observed a very small but reproducible release of the HPN ERdj3
mutant. The amount of release was greater than that observed when wild-type BiP was
used to release the HPN mutant but nowhere near that achieved when the wild-type form
of each protein was used. This suggests that the R197H BiP/HPN ERdj3 proteins do not
constitute a fully functional pair but do possess a small amount of activity together.
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Figure 4-7. R197H BiP cannot be released from D-Luc by either wild-type ERdj3
or the QPD mutant
The experiments were performed exactly the same as in Figure 4-6 except that the R197H
BiP mutant was used to release the various ERdj3 proteins.
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4.4

Discussion

The vast group of proteins that comprise the DnaJ-like family has been subdivided
into three subclasses (Cheetham et al., 1998). The type I and type II proteins bind a
broad spectrum of substrates, whereas the type III protein, which possess only a J domain
that can be found anywhere in the protein, either are not known to interact directly with
substrates or in some cases bind to a much more restricted subset of proteins. There is
now a significant amount of data to argue that DnaJ proteins bind to unfolded proteins
initially and due to their ability to interact specifically with the ATP form of Hsp70s
serve to recruit the open form of the Hsp70 to the substrate. Hsp70 proteins must be able
to interact with a DnaJ protein as well as to bind and hydrolyze ATP in order to be
efficiently recruited to the substrate (Wawrzynow et al., 1995). Data showing that DnaJ
proteins can interact with the SBD of the Hsp70 as well as with its NBD have led
investigators to speculate that this might allow the DnaJ protein to deliver and transfer the
substrate to the correct region of the Hsp70 protein (Laufen et al., 1999). Several models
have been proposed as to how this may occur. First, it is possible that once the DnaJ
protein contacts an Hsp70, it releases the unfolded protein and the Hsp70 captures it
(Rudiger et al., 2001). The identification of stable DnaJ/Hsp70/substrate complexes
(Szabo et al., 1994; Wawrzynow et al., 1995; Han & Christen, 2003; Shen et al., 2005;)
makes this scenario less likely. Second, it has been proposed that the two proteins bind
distinct sequences on the substrate, which is supported by the identification of binding
sites on substrate proteins for DnaK and DnaJ using peptide libraries (Kim et al., 2002;
Han et al., 2003). Once the J domain interacts with the NBD of the Hsp70, it has been
argued that this would reorient the Hsp70 and in some way wrench the substrate from the
DnaJ protein (Landry, 2003). Our demonstration that wild-type BiP, which binds the
substrate but cannot release the QPD or HPN mutant could be interpreted as being
compatible with this model, since the absence of the BiP/ERdj3 interaction might not
allow BiP to wrench the substrate from ERdj3. This wrenching would need to happen
before ATP is hydrolyzed, as DnaJ domains lose affinity for the ADP bound form of
Hsp70 (Wawrzynow & Zylicz, 1995) and maximal stimulation of the ATPase activity of
Hsp70s by DnaJs only occurs after the substrate binds to the Hsp70 (Laufen et al., 1999).
Finally, it is possible that in addition to the conformational change that DnaJ induces in
the Hsp70 protein, that after substrate binding and ATP hydrolysis the Hsp70 protein
causes a reciprocal conformational change in the substrate binding domain of the DnaJ
protein. It is known that DnaJ proteins have a second interaction site with the SBD of
Hsp70s (Laufen et al., 1999), but it is not clear which domain of DnaJ is involved it this
binding (Wall et al., 1995; Wawrzynow et al., 1995; Linke et al., 2003; Sahi & Craig,
2007;) nor how alterations in these interactions affect the structure of DnaJ proteins. Our
data is also compatible with this model.
Our discovery that the release of ERdj3 from substrate is dependent on a functional
interaction with BiP is likely to be true of other DnaJ/Hsp70 pairs. Recent data from
Petrova et al., demonstrate a similar requirement for the release of another ER localized
DnaJ protein, P58, from substrate. In this study P58 was shown to bind directly to
misfolded RNase A in vitro and was released from it by BiP in the presence of ATP and
Mg2+. Mutations in either P58 or BiP that disrupted the interaction between them
blocked the release of P58 from misfolded RNase A. In addition to interactions between
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the nucleotide binding domain of BiP and the ER localized DnaJ protein, this study
further revealed that BiP also needed to bind to the substrate to trigger DnaJ release.
Based on the conservation of interactions between other DnaJ/Hsp70 proteins, we believe
this is likely to be a universal requirement for the release of DnaJs. In support of this, an
earlier in vitro study found that DnaJ bound to a substrate and prevented its aggregation,
but it could not fold the protein unless DnaK and ATP were present (Lu & Cyr, 1998;
Fan et al. 2005). In view of our data, it is reasonable to suggest that DnaJ remained
bound to the substrate in the absence of DnaK, thereby preventing its aggregation, but
also preventing it from folding. Only in the presence of ATP would both chaperones be
released allowing the substrate to fold. We would speculate, based on our data, that in
the absence of ATP that both DnaK and DnaJ might bind, but folding would not occur.
Our previous characterization of the interaction of ERdj3 with substrates in
cultured cell lines revealed that wild-type ERdj3 disappeared from BiP:substrate
complexes long before folding was complete, whereas a QPD mutant remained
associated with the substrate (Shen et al., 2005). This led us to speculate that the
prolonged binding of the QPD mutant to substrates could be due to its inability to
recognize that BiP had bound productively to the substrate. The data presented here
confirm that the release of ERdj3 from substrate, at least in vitro, required an interaction
between the J domain of ERdj3 and NBD of BiP and argue that indeed this is the reason
for prolonged association of mutant ERdj3 with substrates in vivo. The in vitro release of
ERdj3 from substrate also required BiP’s ATPase and substrate binding activity, as
neither the T37G, G227D (this study), nor the NBD alone (Petrova et al., 2008) were able
to release the corresponding DnaJ proteins from their substrates. These requirements
would ensure that once a DnaJ protein engages an unfolded substrate, it would remain
bound to prevent aggregation until it had recruited an open form of Hsp70 to the
substrate, allowed the Hsp70 to initially associate with the substrate and then hydrolyze
ATP to form a more stable interaction. Only when all of these steps had occurred would
the DnaJ protein release from the Hsp70 and from the substrate. This scenario is
consistent with most published data showing that DnaJ proteins bind first and more
transiently than Hsp70, which remain associated until folding is complete.
In summary, our studies show that BiP promotes the release of ERdj3 from
substrates in the presence of ATP. This is not due to a competition for binding sites on
the substrate once BiP is recruited through its association with ERdj3, but rather it
requires a functional interaction between ERdj3 and BiP. This includes both the ability
to physically interact with each other as well as the ability of ERdj3 to stimulate the
ATPase activity of BiP. The fact that similar data was observed with another ERdj/BiP
pair (Petrova et al., 2008) argues that this mechanism is likely to be used for the release
of other DnaJ proteins from substrates.
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CHAPTER 5. DISCUSSION
Many DnaJ proteins can interact directly with unfolded substrates and prevent them
from aggregating in vitro. Crystallographic studies of the C-terminal peptide binding
fragments of Ydj1 (Li et al., 2003) and Sis1 (Sha et al., 2000) determined the putative
substrate binding of domain of DnaJ proteins. The substrate binding characteristics of
mammalian ER DnaJ proteins were poorly understood when I started my project. Since
ERdj3 interacts with unassembled Ig heavy chains unusually stably in vivo, it provided a
good model to study the interaction between a mammalian DnaJ protein and an unfolded
substrate. In my first study (Chapter 2), we characterized the structural requirements for
ERdj3 to bind to substrates by using a combination of in vivo and in vitro assays. Our
data indicates that hydrophobic amino acids in domain I of ERdj3 are conserved with
those of Ydj1 and form a putative substrate binding site. Comparison the structures of
domain I of Ydj1 and Sis1 (Sha et al., 2000) suggests that Sis1 is likely to contain the
same substrate binding site, even though Sis1 was crystallized without a bound peptide.
Together these studies, coupled with mine, suggest that this substrate binding structure
may be common to all type I and II DnaJ proteins. Very recently a structure was solved
for the putative peptide-binding fragment of Hdj1(Hu et al., 2008), a human type II DnaJ
protein. Like Sis1, this fragment was crystallized without a bound peptide, forms dimers,
and has a very similar structure to Ydj1, except that it lacks a domain II.
However, our data revealed that domain II of ERdj3 is also involved in substrate
binding, which is not supported by the Ydj1 structure where the peptide only associated
with domain I. Since Ydj1 was co-crystallized with a small peptide (GWLYEIS), which
is much smaller than natural substrates, it is possible that domain II cooperates with
domain I to form a larger substrate binding site in cells allowing Ydj1 to interact with
larger polypeptides (Figure 5-1A). The other possibility is that domain II stabilizes the
structure of domain I in the absence of substrate (Figure 5-1B), which is supported by the
fact that Ydj1’s structure could only be solved in the presence of peptide. To test this
possibility, we attempted to co-express domain II of ERdj3 (PRSF-II) along with Histagged ERdj3-∆II in bacteria cells and use Ni2+-agarose columns to pull down the
induced proteins. If our hypothesis was correct, we expected that domain II would bind
to the ERdj3-ΔII protein in trans and restore the ability of ERdj3-ΔII to bind to denatured
luciferase in vitro. Unfortunately, domain II is so small (about 40 amino acids) that it
was not expressed at detectable levels. It might be possible to solve this problem by
adding a GST tag to domain II to make a larger protein which might allow it to be
expressed more stably in bacteria. However, the GST tag may affect the ability of
domain II to interact with domain I and could be removed. This could be done by
inserting a cleavage site such as thrombin or factor Xa between the GST tag and domain
II. An alternative way to test whether domain II interacts with domain I to stabilize it
would be to synthesize the domain II polypeptide in vitro. This strategy may be possible
since domain II only has 40 amino acids, which is within the range of what can be
synthesized in vitro. By adding domain II back to our binding assay with ERdj3-∆II, we
could examine its ability to restore ERdj3-∆II binding to D-Luc.
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Figure 5-1.

Potential roles of domain II is ERdj3 structure

(A) cooperate with domain II to bind to substrate (B) stabilize domain I in the absence of
substrate.
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NMR analyses might provide another tool to monitor the possibility that domain II
interacts with domain I in the absence of peptide to stabilize this domain. Since a
structure has been solved for domains I, II, and III of Ydj1 coupled with peptide, the
NMR study of Ydj1 instead of ERdj3 may be a more straightforward way to answer this
question. The size of Ydj1’s domain I is 79 amino acids and with domain II it is 144
amino acids, which is well within the range for NMR studies. Comparing the structures
of a Ydj1 fragment that includes only domain I and II in both the presence and absence of
peptide could give an answer. If domain II binds to domain I in the absence of peptide,
we would expect to see a change in the substrate binding face at domain I when peptide
was added. If domain II serves to provide a larger binding site for different substrates,
we would expect to see no change in the substrate binding face in the presence or absence
of peptide.
It is important to note that type II DnaJ proteins (such as Sis1 and Hdj1), which
lack domain II, can bind to substrates just fine. It has been proposed recently, that
domain I of type II DnaJ proteins may possess significant flexibility (Hu et al., 2008),
which would allow them to adjust the size or shape of the substrate binding cleft. It is
possible that type I proteins achieve this additional flexibility through interactions
between domain I and II. It is also very likely that type I and II DnaJ proteins have
different substrate specificities that require different structures. However,
complementation studies with different DnaJ proteins argue that in most cases these
substrates must but not be essential ones.
Although we decided that overall ERdj3 was structurally very similar to Ydj1, the
four cysteine residues in domain II of ERdj3 form intra-domain disulfide bonds, whereas
the eight cysteines in Ydj1 form two zinc binding sites. Since Ydj1 and ERdj3 belong to
different organisms and exist in different organelles, it was expected that they might not
be interchangeable. Ydj1 expressed in the ER would not bind zinc atoms, and ERdj3
expressed in the cytosol was unlikely to form disulfide bonds. This led us to speculate
that verification of the role of domain II of ERdj3 in substrate interaction would be
possible by creating chimera proteins made up of various combinations of ERdj3 and
Ydj1 domains. The fact that ER expressed Ydj1 can interact with BiP and ERdj3
substrate (Figure 4-2) denied that strategy but led to studies described in Chapter 3. In
this study, we found that ERdj3 could compensate the loss of Ydj1 and that both the
ability to stimulate the ATPase activity of the Hsp70 partner and to bind to substrates
were necessary for ERdj3 to compensate for the loss of Ydj1. Because domain II seems
to be important for ERdj3’s substrate binding function and the intra-domain disulfide
bonds were reported to be critical for substrate binding in vitro, we discussed the three
possibilities in Chapter 3 to account for this. First, we argued that it is possible that the
disulfide bonds do form in ERdj3 even in the relatively reducing environment of the
cytosol. Second, these cysteines may be in a reduced state in the yeast cytosol, but the
formation of disulfide bonds might not be necessary for ERdj3’s function in vivo.
Finally, we suggested that when ERdj3 is expressed in the yeast cytosol, it is possible that
the cysteines in domain II of ERdj3 could bind to Zn2+, which would serve to bridge the
four cysteines and might stabilize this domain by mimicking the conformational stability
that disulfide bonds provide. To verify whether ERdj3 forms disulfide bonds in the yeast
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cytosol, we could express ERdj3 in yeast cells, isolate the protein and then subject it to
reducing and nonreducing SDS-PAGE to check its migration (Figure 5-2). If disulfide
bonds form in the cytosol, we will find that ERdj3 migrates slower in reducing SDSPAGE than under non-reducing conditions (pattern #1). If there is no change in the
migration of the protein with the addition of reducing agents, it would mean either that
disulfide bonds do not form (pattern #2) or that zinc is binding to the cysteines and is not
removed by reducing agents in the sample buffer (pattern #3). To distinguish between
the second and third possibilities, we could compare their mobility to that of reduced and
non-reduced ERdj3 isolated from mammalian cells. If the ERdj3 expressed in yeast
migrates with the reduced form of mammalian ERdj3, it would argue that no disulfide
bonds form, whereas if it migrates faster than the reduced form, it might suggest that zinc
is binding to these cysteines and holding domain II in a more compact form. To test this
possibility, we could treat the ERdj3 isolated from the yeast cytosol with ρhydroxymercuripherysulfon which is sulfhydryl-dissociating reagent and was used to
remove Zinc from DnaJ (Tang et al., 2001).
Although it is fairly well understood how Hsp70 proteins are released from
substrates, very little is known about how DnaJ proteins are released. Our in vivo data
showing that ERdj3 proteins that could not interact with BiP actually resulted in more
ERdj3 being associated with the substrate (Chapter 2) led us to speculate that this might
occur due to decreased release of ERdj3 from substrate and not due to increased binding.
We hypothesized that a functional interaction between DnaJs and Hsp70s might be
required to release DnaJ from substrates. The development of an in vitro binding assay
(Chapter 2) allowed me to test this. Using a series of ERdj3 and BiP mutants with
denatured luciferase as the substrate, we determined that release of ERdj3 required the
ATPase activity of BiP and the ability of ERdj3 and BiP to interact. To demonstrate the
latter point, we used BiP mutants that could not bind to ERdj3 as well as ERdj3 mutants
that could not bind to BiP. We suggested that the interaction with BiP may induce a
reciprocal change in ERdj3 that triggers its release from substrates (Chapter 4). This
allowed us to propose a general model for the release of DnaJ proteins from substrates
(Figure 5-3). However, we did not demonstrate that ERdj3 actually undergoes a
conformational change in that study. Protease sensitivity is a method that is often used to
measure conformational changes. It is tricky for our assay, since we would need to
retrieve ERdj3 protein bound to substrate and BiP and compare it to released ERdj3. We
would expect there to be changes in protease sensitivity due to substrate binding that
could not be easily distinguished from conformational changes in ERdj3 itself.
Conformational changes can also be monitored by measuring changes in tryptophan
fluorescence. This assay has been used to monitor conformational changes in Hsp70
proteins that occur in response to nucleotide binding. This type of assay is dependent on
the local environment of the tryptophan changing in response to a larger conformational
change in the protein. It is possible that this could be an alternative way to answer the
question. Among the three proteins in our reaction, there are no tryptophan residues in
luciferase, two in BiP (which would have to be mutated), and only one in ERdj3, which
occurs in domain III. If no change is observed, we would probably need to engineer
another tryptophan into another region of ERdj3, although it is not clear where the best
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Figure 5-2.

Potential patterns of cytosolic ERdj3
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Figure 5-3.

Model for dissociation of ERdj3 from substrate proteins

ERdj3 binds directly to substrates and recruits the ATP bound form of BiP. A transient
3-way complex is formed. ERdj3 activates the ATPase activity of BiP, which decreases
the affinity of ERdj3 for BiP (step 1) and induces a conformational change in the
substrate binding domain of BiP, which stabilizes its binding substrate (step 2). We
hypothesis that this interaction triggers a reciprocal conformational change in ERdj3 that
decreases its affinity for substrate (step 3), allowing it to dissociate.
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place to put the tryptophan would be. Alternatively, it might be necessary to switch to
another DnaJ protein.
A separate limitation of our study (Chapter 4) was that all of our BiP ATPase
mutants were also defective in binding to ERdj3, which made it impossible to separate
which defect led to an inability to release ERdj3 from substrate. A recent paper reported
that the E175S Hsc70 mutant has a very low ATPase activity but is still able to bind to
DnaJ proteins (Jiang et al., 2007). Our lab had previously produced the corresponding
point mutation in hamster BiP (E201G) and reported that it has very low ATPase activity,
but still can bind ATP and substrate (Gaut & Hendershot, 1993). If this BiP mutant
behaves the same as the E175S Hsc70 mutant and is able to interact with ERdj3, we
could use it in our release assay to examine whether both the ATPase activity and binding
to ERdj3 are required or if only the binding to ERdj3 is sufficient for its release.
In conclusion, our studies characterized the structural requirements for ERdj3’s
ability to bind to substrates and further determined the requirements for producing
functional Hsp70-DnaJ pairs. In addition, my studies provided further insights on the
mechanism used to release ERdj3 from substrates. The fact that Hsp70s and DnaJ
proteins are so well conserved suggests that our findings have general implications for
Hsp70-DnaJ pairs. Hopefully our data will encourage others to further explore these
possibilities.
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Figure A-1.

Schematic drawings of the domain structure of Ydj1, Scj1 and ERdj3

According to Ydj1’s crystal structure, domain II is intercepted in domain I and separates
it into two halves: Ia and Ib, which fold together to form the intact substrate binding site.
Scj1 is a type I DnaJ protein in yeast ER. It is predicted to have the similar structure as
Ydj1 except the N-terminus ER signal sequence, which is cleaved from the mature
protein. ERdj3 is considered to be a type I DnaJ protein also, although it contains a
smaller domain II. light blue: ER signal sequence; black: J domain; yellow: G/F; red:
domain I; green: domain II; blue: domain III.
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Figure A-2.

Expression of Ydj1 in mammalian ER

Two ER targeting form of Ydj1 were expressed in COS-1 cells that had been grown on
coverslips. ssYdj1 has an ER signal sequence engineered at it N-terminus, and ssYdj1
C406S was generated by adding the N-terminus signal sequence and removing the Cterminus farnesylation site. Both are constructed in the 3HA-DSL vector and have Cterminus HA-tag. Cells were fixed and stained with an anti-HA antibody followed by
FITC goat-anti-mouse IgG. Grp94, an abundant ER luminal protein that served as
control for ER localization, was detected with an anti-Grp94 antiserum followed by
TRITC conjugated goat-anti-rabbit IgG.

85

Figure A-3.

Expression of the various wild-type and mutant ERdj3 in yeast

Wild-type HLJ1YDJ1 (A) and mutant hlj1Δydj1-151 (B) yeast strains containing an
empty vector (-), or expression vectors for an ER-targeted form of ERdj3 (ssERdj3), an
ER-tethered cytosolically localized form of full-length ERdj3 (CaaX) or CaaX mutants
(CaaX-ΔII-GSGG, CaaX-F326D, CaaX-I134A, CaaX-L208A and CaaX-IVLFa) were
immunostained with antibodies against ER-lumenal Kar2p (TRITC labeled secondary
antibody) and ERdj3 (FITC labeled secondary antibody). DAPI was used to visualize the
nuclear DNA.
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Figure B-1.
themselves

WT/∆J ERdj3 do not bind to Protein A Sepharose beads by

Cos-1 cells were transfected with cDNAs encoding HA-tagged versions of wild type
ERdj3, a mutant that lacked the J domain (∆J) or one that had a mutation which disrupted
the BiP interaction site (HPD→ QPD). Forty hours post-transfection, cells were
metabolically labeled for 3hrs and treated with DSP as in Figure 4-1. After quenching,
cell lysates were made and immunoprecipitated with either anti-HA or Protein A
Sepharose alone. Isolated proteins were separated by reducing SDS-PAGE.
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Figure B-2.
wells

Neither WT nor mutants BiP bind non-specifically to BSA blocked

Plate ELISA assays were performed as in Figure 4-4 except that denatured luciferase was
not used to coat the wells. Briefly, 200 μl of PBS containing 1% BSA was added to
block the wells and incubate for 1hr at RT. After washing, recombinant wild-type or the
indicated BiP mutant proteins (5 µM) were added and incubated for 1 hr at RT. After
washing, the amount of BiP that bound non-specifically to the wells was detected with a
polyclonal anti-BiP antiserum, followed by donkey anti-rabbit Ig conjugated to alkaline
phosphatase. The signal was detected as described in Figure 4-4.
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